Metrikler
Yayın
345
Açık Erişim
32
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
1993 - 1996
1993 - 1996Tıpta Yandal Uzmanlık
Ankara Üniversitesi, Ankara Tıp Fakültesi, Türkiye
1988 - 1993
1988 - 1993Tıpta Uzmanlık
Diğer (Kurumlar,hastaneler Vb.), Hastaneler, Ankara Dışkapı Yıldırım Beyazıt Eğitim Ve Araştırma Hastanesi, Türkiye
1982 - 1988
1982 - 1988Lisans
Hacettepe Üniversitesi, Tıp Fakültesi, Türkiye
Yabancı Diller
C1 İleri
C1 İleriİngilizce
Araştırma Alanları
Sağlık Bilimleri
Dahili Tıp Bilimleri
Onkoloji
Akademik Ünvanlar / Görevler
2003 - Devam Ediyor
2003 - Devam EdiyorProf. Dr.
Ankara Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
Yönetimsel Görevler
2018 - Devam Ediyor
2018 - Devam EdiyorEnstitü Müdürü
Ankara Üniversitesi
Yönetilen Tezler
2018
2018Tıpta Uzmanlık
Rutin tedavi olarak bevacizumab kullanılan metastatik kolorektal kenserli kolorektal kanserli hastalarda tedavi etkinliğinin belirlenmesinde biyobelirteçlerin rolü
AKBULUT H. (Danışman)
B.AKAY(Öğrenci)
2017
2017Yüksek Lisans
Kanser hücrelerinde anjiyogenik faktörlerin ekspresyonuna kemoterapinin etkilerinin incelenmesi
AKBULUT H. (Danışman)
M.ÖÇAL(Öğrenci)
2017
2017Yüksek Lisans
Anti-anjiyogenik ilaç tedavisinin tümör immünitesi üzerindeki etkilerinin araştırılması
AKBULUT H. (Danışman)
S.ABDI(Öğrenci)
2017
2017Yüksek Lisans
Tümör hücrelerindeki PD-L1 ekspresyonunun anjiyogenez ve invazyon üzerine etkisi
AKBULUT H. (Danışman)
C.BABAHAN(Öğrenci)
2017
2017Yüksek Lisans
Metronomik kemoterapinin endotel hücre fonksiyonları üzerindeki etkisi
AKBULUT H. (Danışman)
F.GİZEM(Öğrenci)
2016
2016Tıpta Uzmanlık
Bevasizumab alan metastatik kolon kanserli olgularda CEA ve histopatolojik özelliklerin değerlendirilmesi
AKBULUT H. (Danışman)
F.SENA(Öğrenci)
2015
2015Doktora
Bakuloviral vektörler aracılı sitokin ve intihar gen tedavileri
AKBULUT H. (Danışman)
S.HANDE(Öğrenci)
2014
2014Tıpta Uzmanlık
Metastatik kolorektal kanserli hastalarda setuksimab ve bevasizumabın etkinliğinin değerlendirilmesi retrospektif çalışma
AKBULUT H. (Danışman)
Ö.GERÇİK(Öğrenci)
2013
2013Yüksek Lisans
Kolorektal kanserli hastalarda kök hücre gen ekspresyon profili ve prognostik önemi
AKBULUT H. (Danışman)
S.ÖZTOP(Öğrenci)
2013
2013Tıpta Uzmanlık
Tamoksifen direncinde survivin gen ekspresyonunun klinik önemi
AKBULUT H. (Danışman)
İ.DEDE(Öğrenci)
2011
2011Tıpta Uzmanlık
Mide kanserinde kemoterapi yanıtı ve direncinde osteopontinin rolü
AKBULUT H. (Danışman)
O.YAZICI(Öğrenci)
2011
2011Tıpta Yandal Uzmanlık
Kolorektal kanserli hastalarda karaciğer metastazlarını saptamada serum golgi protein 73'ün yeri
AKBULUT H. (Danışman)
F.GÜZE(Öğrenci)
2011
2011Doktora
Kanserde damar endoteline yönelik gen tedavisi ajanları geliştirilmesi
AKBULUT H. (Danışman)
P.BAYDIN(Öğrenci)
2010
2010Yüksek Lisans
Kemoterapinin kolon kanseri, meme kanseri ve mide kanserinde VEGF düzeylerine etkisinin in vivo ve in vitro incelemesi
AKBULUT H. (Danışman)
S.HANDE(Öğrenci)
2005
2005Tıpta Uzmanlık
Küçük hücreli dışı akciğer kanserinde tedaviye yanıt ile serum EGFR düzeyi arasındaki ilişki
AKBULUT H. (Danışman)
İ.TEK(Öğrenci)
2003
2003Tıpta Uzmanlık
Meme kanserinde serum telomeraz aktivitesi ve kemoterapi direncinin belirlenmesinde ve hastalık prognozundaki rolü
AKBULUT H. (Danışman)
Ş.TEMİZKAN(Öğrenci)
2000
2000Tıpta Uzmanlık
Kolorektal kanserlerde anjiyogenetik faktörlerin prognostik önemi
AKBULUT H. (Danışman)
F.ALTUNTAŞ(Öğrenci)
1999
1999Tıpta Uzmanlık
İleri evre mide kanserli hastalarda kronoterapinin yaşam kalitesi üzerine etkisinin araştırılması: Prospektif randomize "cross-over" çalışma
AKBULUT H. (Danışman)
B.YALÇIN(Öğrenci)
Makaleler
Tümü (178)
SCI-E, SSCI, AHCI (154)
SCI-E, SSCI, AHCI, ESCI (156)
ESCI (2)
Scopus (172)
TRDizin (17)
Diğer Yayınlar (4)
2025
20251. Comparison of AI chatbot predicted and realworld survival outcomes in hepatocellular carcinoma
Kavak E. E., Erdat E. C., Altundağ Derin Z., Dilli İ., KUBİLAY TOLUNAY P., Öksüzoğlu B., et al.
Scientific Reports
, cilt.15, sa.1, 2025 (SCI-Expanded, Scopus)
2025
20252. Treatment approaches and survival outcomes in elderly colorectal cancer patients: a single-center comparative study
KARAOĞLAN B. B., AKKUŞ E., Kayaalp M., AKYOL C., ERKEK A. B., AKBULUT H., et al.
Clinical and Translational Oncology
, cilt.27, sa.5, ss.2292-2306, 2025 (SCI-Expanded, Scopus)
2025
20253. Predicting liver metastasis in colorectal cancer patients using routine biochemical tests enhanced by machine learning
ERDAT E. C., YALÇINER M., Kavak E. E., Dilli I., Cakmak Oksuzoglu O. B., AKBULUT H., et al.
Clinical and Translational Oncology
, 2025 (SCI-Expanded, Scopus)
2021
20214. ctDNA as a prognostic factor in operable colon cancer patients: a systematic review and meta-analysis
Yekeduz E., KÖKSOY E. B., AKBULUT H., ÜRÜN Y., UTKAN G.
FUTURE ONCOLOGY
, cilt.17, sa.03, ss.349-357, 2021 (SCI-Expanded, Scopus)
2020
20205. Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study
Jazieh A. R., AKBULUT H., Curigliano G., Rogado A., Alsharm A. A., Razis E. D., et al.
JCO GLOBAL ONCOLOGY
, cilt.6, ss.1428-1438, 2020 (ESCI, Scopus)
2020
20206. Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine plus nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study
YALÇIN Ş., Dane F., Oksuzoglu B., Ozdemir N. Y., Isikdogan A., ÖZKAN M., et al.
BMC CANCER
, cilt.20, sa.1, 2020 (SCI-Expanded, Scopus)
2020
20207. Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study
Yasar H. A., Turna H., Esin E., Sedef A. M., Alkan A., Oksuzoglu B., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.26, sa.2, ss.267-272, 2020 (SCI-Expanded, Scopus)
2020
20208. The Impact of Loneliness and Cancer Diagnosis on Cognitive Impairment in Geriatric Patients
ALKAN A., ÜRÜN Y., UTKAN G., AKBULUT H., TUNCAY G., ARAS S., et al.
Journal of Oncological Sciences
, cilt.6, sa.2, ss.65-70, 2020 (TRDizin)
2020
20209. Immune gene therapy of cancer
AKBULUT H.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.50, ss.1679-1690, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
202010. The Impact of Loneliness and Cancer Diagnosis on Cognitive Impairment in Geriatric Patients.
ALKAN A., ÖZTORUN H. S., KARCI E., ÜRÜN Y., TUNCAY G., YAŞAR H. A., et al.
Journal of Oncological Sciences , cilt.6, sa.2, ss.65-70, 2020 (TRDizin)
2019
201911. Oxidative Stress and Sirtuin2 Changes in Different Parts of the Brain in Aging: Protective Effect of Melatonin
AKBULUT K. G., Aktan A. K., Abgarmi S. A., AKBULUT H.
ACTA PHYSIOLOGICA
, cilt.227, ss.91, 2019 (SCI-Expanded, Scopus)
2019
201912. Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study
ÜRÜN Y., Yasar H. A., TURNA Z. H., Esin E., Sedef A. M., Alkan A., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.25, sa.7, ss.1658-1664, 2019 (SCI-Expanded, Scopus)
2019
201913. The Role of Tumor Microenvironment in Genomic Instability of Malignant Tumors
SONUGÜR F. G., AKBULUT H.
FRONTIERS IN GENETICS
, cilt.10, 2019 (SCI-Expanded, Scopus)
2019
201914. A Bicistronic Adenoviral Vector Carrying Cytosine Deaminase and Granulocyte-Macrophage Colony-Stimulating Factor Increases the Therapeutic Efficacy of Cancer Gene Therapy
AKBULUT H., ÇÖLERİ CİHAN A., ŞAHİN G., Tang Y., Icli F.
HUMAN GENE THERAPY
, cilt.30, sa.8, ss.999-1007, 2019 (SCI-Expanded, Scopus)
2019
201915. Tumor-associated Macrophages and Neuroendocrine Differentiation Decrease the Efficacy of Bevacizumab Plus Chemotherapy in Patients With Advanced Colorectal Cancer
Gunay F. S. D., KIRMIZI B. A., ENSARİ A., Icli F., AKBULUT H.
CLINICAL COLORECTAL CANCER
, cilt.18, sa.2, 2019 (SCI-Expanded, Scopus)
2019
201916. Following Chemotherapy: Serum Cytokine (Tumor Necrosis Factor, Interleukin-2, Interleukin-11), Immunoglobulin, Complement, Vascular Endothelial Growth Factor Levels, and the Systemic Symptoms like Capillary Leak Syndrome
Keskin H., Cadirci K., Demirkazık A., Akbulut H., Yalçın B.
Biomarkers in Cancer
, cilt.11, 2019 (Hakemli Dergi)
2019
201917. Recent advances in cancer stem cell targeted therapy
AKBULUT H., BABAHAN C., Abgarmi S. A., Ocal M., Besler M.
Critical Reviews in Oncogenesis
, cilt.24, sa.1, ss.1-20, 2019 (Scopus)
2018
201818. Neuroprotective Effects of Sirt2 Inhibition In Aging
Aktan A. K., AKBULUT K. G., AKBULUT H.
ACTA PHYSIOLOGICA
, cilt.225, ss.30, 2018 (SCI-Expanded, Scopus)
2018
201819. Age-Related Changes in the Oxidative Stress, Apoptosis, SIRT2 and Autophagy in the Cerebral Cortex: Protective Effects of Melatonin
AKBULUT K. G., Keskin-Aktan A., Abgarmi S. A., AKBULUT H.
ACTA PHYSIOLOGICA
, cilt.225, ss.37, 2018 (SCI-Expanded, Scopus)
2018
201820. Risk factors for thrombosis risk in patients with cancer
TURAN D., YAŞAR H. A., Aksu O. B., KÖKSOY E. B., UTKAN G., AKBULUT H., et al.
Journal of Oncological Sciences
, cilt.4, sa.3, ss.130-133, 2018 (Hakemli Dergi)
2018
201821. Diagnostic serum vitamin D level is not a reliable prognostic factor for resectable breast cancer
Kaya D. M., Orturk B., Kubilay P., Onur H., UTKAN G., ÇAY ŞENLER F., et al.
FUTURE ONCOLOGY
, sa.15, ss.1461-1467, 2018 (SCI-Expanded, Scopus)
2018
201822. The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.
AKBULUT H., Ocal M., Sonugur F. G., Abgarmi S. A., BABAHAN C., Akay B., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.36, sa.15, 2018 (SCI-Expanded, Scopus)
2018
201823. The effects of melatonin and curcumin on the expression of SIRT2, Bcl-2 and Bax in the hippocampus of adult rats
Keskin-Aktan A., Akbulut K. G., Yazici-Mutlu C., Sonugür F. G., Ocal M., Akbulut H.
BRAIN RESEARCH BULLETIN
, ss.306-310, 2018 (SCI-Expanded, Scopus)
2017
201724. The Effects of Curcumin Administration on Hippocampal SIRT2, BCL-2, BAX And BIM Expressions in Young and Aged Rats
Aktan A. K., AKBULUT K. G., AKBULUT H.
ACTA PHYSIOLOGICA
, cilt.221, ss.25-26, 2017 (SCI-Expanded, Scopus)
2017
201725. Significance of tumour-infiltrating lymphocytes (TILs) in gastric carcinomas: Association of PD-L1 and PD-1 expression with prognostic parameters and survival
Arman A. F., Yasar H. A., Savas B., AKBULUT H., ENSARİ A.
VIRCHOWS ARCHIV
, cilt.471, 2017 (SCI-Expanded, Scopus)
2017
201726. Vaccination in oncology practice and predictors
Alkan A., Karci E., Yasar A., Tuncay G., KÖKSOY E. B., Urun M., et al.
SUPPORTIVE CARE IN CANCER
, cilt.25, sa.9, ss.2677-2682, 2017 (SCI-Expanded, Scopus)
2017
201727. The significance of serum leptin level in patients with early stage nonsmall cell lung cancer
Karatas F., YALÇIN B., Sahin S., AKBULUT H., UTKAN G., DEMİRKAZIK A., et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
, cilt.13, sa.2, ss.204-207, 2017 (SCI-Expanded, Scopus)
2017
201728. Aflibercept-related nasal septum perforation
Alkan A., Yucel L., Mizrak D., AKBULUT H.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
, cilt.13, sa.2, 2017 (SCI-Expanded, Scopus)
2017
201729. A new angiogenesis prognostic index with VEGFA, PlGF, and angiopoietin 1 predicts survival in patients with advanced gastric cancer
Aktas S. H., AKBULUT H., Yazici O., Zengin N., Akgun H. N., Ustuner Z., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.47, sa.2, ss.399-406, 2017 (SCI-Expanded, Scopus, TRDizin)
2017
201730. Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients
Alkan A., Yasar A., Karci E., KÖKSOY E. B., Urun M., ÇAY ŞENLER F., et al.
SUPPORTIVE CARE IN CANCER
, cilt.25, sa.1, ss.229-236, 2017 (SCI-Expanded, Scopus)
2016
201631. Prognostic Importance of Bone Marrow Uptake on Baseline F-18-FDG Positron Emission Tomography in Diffuse Large B Cell Lymphoma
SOYDAL Ç., KÖKSOY E. B., Yasar A., Turgal E., DOĞANAY ERDOĞAN B., AKBULUT H., et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
, cilt.31, sa.10, ss.361-365, 2016 (SCI-Expanded, Scopus)
2016
201632. The role of immune system on the efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC)
AKBULUT H., Ocal M., Sonugur G., AKAY B. N., BABAHAN C., Abgarmi S. A., et al.
ANNALS OF ONCOLOGY
, cilt.27, 2016 (SCI-Expanded, Scopus)
2016
201633. Medical oncologists' attitudes towards vaccination in oncology practice
Alkan A., Karci E., Yasar A., Tuncay G., Urun M., Koksoy E. B., et al.
ANNALS OF ONCOLOGY
, cilt.27, 2016 (SCI-Expanded, Scopus)
2016
201634. Breast cancer survivors suffer from persistent postmastectomy pain syndrome and posttraumatic stress disorder (ORTHUS study): a study of the palliative care working committee of the Turkish Oncology Group (TOG)
Alkan A., Guc Z. G., ÇAY ŞENLER F., YAVUZŞEN T., Onur H., Dogan M., et al.
SUPPORTIVE CARE IN CANCER
, cilt.24, sa.9, ss.3747-3755, 2016 (SCI-Expanded, Scopus)
2016
201635. A novel fluorescence turn-on coumarin-pyrazolone based monomethine probe for biothiol detection
Babur B., SEFEROĞLU N., Ocal M., SONUGÜR F. G., AKBULUT H., SEFEROĞLU Z.
TETRAHEDRON
, sa.30, ss.4498-4502, 2016 (SCI-Expanded, Scopus)
2016
201636. Baculoviral vector loaded mesenchymal stem cells as efficient gene therapy tools for cancer treatment
Aktas S. H., Akbulut H., Elçin A. E., Parmaksız M., Keskin A. A., Çöleri Cihan A., et al.
TURKISH JOURNAL OF BIOLOGY
, cilt.40, sa.5, ss.1121-1128, 2016 (SCI-Expanded, Scopus, TRDizin)
2015
201537. The Effect of Melatonin, Curcumin and Salermide on Sirt2 expression Level of Hippocampus in Middle Aged Rats
AKBULUT K. G., Aktan A. K., Mutlu C. Y., AKBULUT H.
ACTA PHYSIOLOGICA
, cilt.215, ss.44, 2015 (SCI-Expanded, Scopus)
2015
201538. Nine weeks versus 1 year adjuvant trastuzumab in patients with early breast cancer: an observational study by the Turkish Oncology Group (TOG)
Icli F., Altundag K., AKBULUT H., PAYDAŞ S., BAŞARAN G., Saip P., et al.
BREAST CANCER
, cilt.22, sa.5, ss.480-485, 2015 (SCI-Expanded, Scopus)
2015
201539. More prognostic factors in early stage breast cancer
Mizrak D., Ozturk B., Kubilay P., AKBULUT H., Onur H.
BREAST
, cilt.24, 2015 (SCI-Expanded, Scopus)
2015
201540. Effect of tumor hormonal and HER2 status on localization of metastases in recurrent breast cancer
Mizrak D., Onur H., Ozturk B., Kubilay P., AKBULUT H.
BREAST
, cilt.24, 2015 (SCI-Expanded, Scopus)
2015
201541. Effect of HER2 and hormonal status to FDG uptake on PET/CT imaging in recurrent breast cancer
Mizrak D., Onur H., Ozturk B., Kubilay P., Utkan G., AKBULUT H.
BREAST
, cilt.24, 2015 (SCI-Expanded, Scopus)
2015
201542. Serum levels of CEA and CA 15-3 in different subtypes of recurrent breast cancer
Mizrak D., Ozturk B., Kubilay P., AKBULUT H., Onur H.
BREAST
, cilt.24, 2015 (SCI-Expanded, Scopus)
2015
201543. Preoperative systemic therapy for locally advanced breast cancer: single center experience
Mizrak D., Kubilay P., Ozturk B., Onur H., AKBULUT H.
BREAST
, cilt.24, 2015 (SCI-Expanded, Scopus)
2015
201544. Blood group: is it associated with tumor biology in breast cancer?
Mizrak D., Kubilay P., Ozturk B., AKBULUT H., Onur H.
BREAST
, cilt.24, 2015 (SCI-Expanded, Scopus)
2015
201545. The role of cardiac biomarkers as predictors of trastuzumab cardiotoxicity in patients with breast cancer
ÜRÜN Y., UTKAN G., Yalcin B., AKBULUT H., Onur H., Oztuna D., et al.
Experimental Oncology
, cilt.37, sa.1, ss.53-57, 2015 (SCI-Expanded, Scopus)
2015
201546. Epidemiology of colorectal cancer in Turkey: A cross-sectional disease registry study (A Turkish Oncology Group trial)
Aykan N. F., YALÇIN Ş., Turhal N. S., Ozdogan M., Demir G., ÖZKAN M., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.26, sa.2, ss.145-153, 2015 (SCI-Expanded, Scopus, TRDizin)
2015
201547. The role of melatonin, sirtuin2 and FoXO1 transcription factor in the aging process of colon in male rats
AKBULUT K. G., Aktas S. H., AKBULUT H.
BIOGERONTOLOGY
, cilt.16, sa.1, ss.99-108, 2015 (SCI-Expanded, Scopus)
2015
201548. Cancer patient and hunger
Mizrak D., AKBULUT H.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
, cilt.30, sa.3, ss.152-157, 2015 (ESCI, Scopus)
2015
201549. The role of cardiac biomarkers as predictors of trastuzumab cardiotoxicity in patients with breast cancer
Ürun Y., UTKAN G., Yalcin B., AKBULUT H., Onur H., DG O., et al.
Experimental oncology
, cilt.37, sa.1, ss.53-7, 2015 (Scopus)
2014
201450. Fighting Against Cigarette Smoking Among Medical Students: A Success Story
Icli F., ODABAŞ D., Gonullu U., Sunguroglu K., Akdur R., AKBULUT H., et al.
JOURNAL OF CANCER EDUCATION
, cilt.29, sa.3, ss.458-462, 2014 (SCI-Expanded, Scopus)
2014
201451. The Relationship Between Common EGFR, BRAF, KRAS Mutations and Prognosis in Advanced Stage Non-Small Cell Lung Cancer with Response to the Treatment in Turkey
Dogan M., DEMİRKAZIK A., Tukun A., SAK S., CEYHAN K., Yalcin B., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.1, ss.1-10, 2014 (SCI-Expanded, Scopus, TRDizin)
2013
201352. Designing gene therapy vectors targeting tumor cell endothelium Kanserde damar endoteline yönelik gen tedavisi ajanlari{dotless} geliştirilmesi
Özkal Baydin P., AKBULUT H.
Turk Onkoloji Dergisi
, cilt.28, sa.4, ss.179-186, 2013 (SCI-Expanded, Scopus)
2013
201353. Melatonin Delays Brain Aging by Decreasing the Nitric Oxide Level
Akbulut K. G., Guney S., Cetin F., Akgun H. N., Aktas S. H., AKBULUT H.
NEUROPHYSIOLOGY
, cilt.45, sa.3, ss.187-192, 2013 (SCI-Expanded, Scopus)
2013
201354. Perception about influenza and pneumococcal vaccines and vaccination coverage among patients with malignancies and their family members
ÜRÜN Y., AKBULUT H., DEMİRKAZIK A., Senler F. C., Utkan G., Onur H., et al.
JOURNAL OF BUON
, cilt.18, sa.2, ss.511-515, 2013 (SCI-Expanded, Scopus)
2013
201355. TAA/ecdCD40L adenoviral prime-protein boost vaccine for cancer and infectious diseases
Deisseroth A., Tang Y., Zhang L., AKBULUT H., Habib N.
CANCER GENE THERAPY
, cilt.20, sa.2, ss.65-69, 2013 (SCI-Expanded, Scopus)
2013
201356. Smoking Habits of Relatives of Patients with Cancer: Cancer Diagnosis in the Family is an Important Teachable Moment for Smoking Cessation
HAYRAN K. M., Kilickap S., ELKIRAN E. T., AKBULUT H., Abali H., YÜCE D., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.14, sa.1, ss.475-479, 2013 (SCI-Expanded, Scopus)
2012
201257. Retrospective analysis of seventy-one patients with neuroendocrine tumor and review of the literature
Dogan M., Yalcin B., Ozdemir N. Y., Arslan U. Y., Dogan L., UTKAN G., et al.
MEDICAL ONCOLOGY
, cilt.29, sa.3, ss.2021-2026, 2012 (SCI-Expanded, Scopus)
2012
201258. ABO and Rh blood groups frequency in women with HER2 positive breast cancer
ÜRÜN Y., Utkan G., Altundag K., Arslan O., Onur H., Arslan U. Y., et al.
JOURNAL OF BUON
, cilt.17, sa.3, ss.457-460, 2012 (SCI-Expanded, Scopus)
2012
201259. Primary extranodal non-Hodgkin's lymphoma presenting as painful gingival swelling
ÜRÜN Y., Can F., BARIŞ E., AKBULUT H., UTKAN G., Içli F.
Experimental Oncology
, cilt.34, sa.2, ss.134-135, 2012 (SCI-Expanded, Scopus)
2012
201260. Melatonin decreases apoptosis in gastric mucosa during aging
AKBULUT K. G., AKBULUT H., Akgun N., Gonul B.
AGING CLINICAL AND EXPERIMENTAL RESEARCH
, cilt.24, sa.1, ss.15-20, 2012 (SCI-Expanded, Scopus)
2012
201261. Low dose chemotherapeutic drugs without overt cytotoxic effects decrease the secretion of VEGF by cultured human tumor cells: A tentative relationship between drug type and tumor cell type response
Aktas S. H., AKBULUT H., Akgun N., Icli F.
CANCER BIOMARKERS
, cilt.12, sa.3, ss.135-140, 2012 (SCI-Expanded, Scopus)
2012
201262. ABO and Rh Blood Groups and Risk of Colorectal Adenocarcinoma
ÜRÜN Y., Ozdemir N. Y., UTKAN G., AKBULUT H., SAVAŞ B., Oksuzoglu B., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, sa.12, ss.6097-6100, 2012 (SCI-Expanded, Scopus)
2012
201263. Relationship Between Antimetabolite Toxicity and Pharmacogenetics in Turkish Cancer Patients
Dogan M., KARABULUT H. G., Tukun A., DEMİRKAZIK A., UTKAN G., Yalcin B., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.13, sa.4, ss.1553-1556, 2012 (SCI-Expanded, Scopus)
2012
201264. Lack of Any Relationship between ABO and Rh Blood Groups and Clinicopathological Features in Patients with Gastrointestinal Stromal Tumors: Turkish Oncology Group
ÜRÜN Y., Utkan G., YALÇIN Ş., COŞKUN H. Ş., Kocer M., Ozdemir N. Y., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, sa.8, ss.4129-4131, 2012 (SCI-Expanded, Scopus)
2012
201265. Characteristics of Oropharyngeal Candida and Bacterial Colonization in Cancer Patients
ÇAY ŞENLER F., Cakmakci S., Akan O. A., DEMİRKAZIK A., AKBULUT H., Icli F.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.22, sa.2, ss.113-119, 2012 (SCI-Expanded, Scopus, TRDizin)
2011
201166. Angiosarcoma related to immunosuppressive therapy 8 years after renal transplantation
ÜRÜN Y., DOĞAN İ., KİREMİTCİ S., AKBULUT H., Icli F.
ANNALS OF TRANSPLANTATION
, cilt.16, sa.4, ss.138-140, 2011 (SCI-Expanded, Scopus)
2011
201167. The effect of age and Helicobacter pylori infection on gastric epithelial cell kinetics
Coban S., Soykan I., TÖRÜNER M., AKBULUT H., Atli T., ENSARİ A.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
, cilt.35, sa.10, ss.661-665, 2011 (SCI-Expanded, Scopus)
2011
201168. The role of Phe329 in binding of cationic triarylmethane dyes to human butyrylcholinesterase
BİBEROĞLU K., TACAL Ö., AKBULUT H.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
, cilt.511, sa.1-2, ss.64-68, 2011 (SCI-Expanded, Scopus)
2011
201169. Assessment of immature teratoma by 18F-FDG PET/CT
ÖZKAN E., Yagci S., Dogan M., Lacin S., KÜÇÜK N. Ö., AKBULUT H.
European Journal of Radiology Extra
, cilt.78, sa.3, 2011 (Scopus)
2011
201170. Lymphoproliferative Disorders in Individuals With Chronic Hepatitis B and C in the Turkish Population
İDİLMAN R., Bozkus Y., CENGİZ SEVAL G., Mizrak D., ÇINAR K., Ustun Y., et al.
JOURNAL OF MEDICAL VIROLOGY
, cilt.83, sa.6, ss.974-980, 2011 (SCI-Expanded, Scopus)
2011
201171. The role of serum osteopontin (OPN) as a prognostic and predictive marker in patients with advanced gastric cancer.
Yazici O., AKBULUT H., Akgun N., Utkan G., Yalcin B., Icli F.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.29, sa.15, 2011 (SCI-Expanded, Scopus)
2011
201172. The relationship between common EGFR, b-raf, k-ras mutations, and prognosis in advanced-stage NSCLC with response to the treatment
Dogan M., Demirkazik A., Tukun A., AKBULUT H., SAK S., Ceyhan K., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.29, sa.15, 2011 (SCI-Expanded, Scopus)
2011
201173. Golgi protein 73 (gp73) is a useful tumor marker in patients with colon cancer.
Ozal G., AKBULUT H., Akgun N., Cipe G., Icli F.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.29, sa.15, 2011 (SCI-Expanded, Scopus)
2011
201174. The association between sociodemographic parameters and the use of complementary interventions in patients with cancer in Turkey: A Turkish Oncology Group study.
Turhal N. S., Kilickap S., Yalcin S., Sezgin C., Yamac D., AKBULUT H., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.29, sa.15, 2011 (SCI-Expanded, Scopus)
2011
201175. The changing pattern of risk factors and disease characteristics of breast cancer in Turkey: A cross-sectional study of a Turkish oncology group (BREASTTURK)
AKBULUT H., Altundag M. K., Saip P., COŞKUN H. Ş., Camci C., Ozkan M., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.29, sa.15, 2011 (SCI-Expanded, Scopus)
2011
201176. Adjuvant oral etoposide plus cisplatin (EoP) following sequential doxorubicin/cyclophosphamide (AC) and docetaxel (T) in early breast cancer patients with 4 or more positive lymph nodes (10 years follow-up)
Icli F., AKBULUT H., Onur H., Yalcin B., DEMİRKAZIK A., ÇAY ŞENLER F.
BREAST
, cilt.20, sa.2, ss.155-157, 2011 (SCI-Expanded, Scopus)
2011
201177. Education, economic status and other risk factors in gastric cancer: "a case-control study of Turkish oncology group"
Icli F., AKBULUT H., Yalcin B., Ozdemir F., Isikdogan A., HAYRAN K. M., et al.
MEDICAL ONCOLOGY
, cilt.28, sa.1, ss.112-120, 2011 (SCI-Expanded, Scopus)
2011
201178. Profile of the colorectal (CRC) cancer (Ca) patients (PTS) in Turkey: A cross-sectional disease registry study-A Turkish Oncology Group trial
Aykan N., Demir G., Disci R., Yalcin S., Turhal N. S., Ozdogan M., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.29, sa.4, 2011 (SCI-Expanded, Scopus)
2010
201079. The Effects of Chronomodulated Therapy with 5 Fluorouracil 5 Fu and Folinic Acid Fa on the Toxicity and Quality of Life in Patients with Advanced Gastric Cancer
YALÇIN B., AKBULUT H., ABDULLAH B., ŞENCAN O., DEMİRKAZIK A., ONUR H., et al.
Biological Rhythm Research , cilt.35, sa.4, ss.259-268, 2010 (Hakemli Dergi)
2010
201080. Addition of adenoviral vector targeting of chemotherapy to the MUC-1/ecdCD40L VPPP vector prime protein boost vaccine prolongs survival of mice carrying growing subcutaneous deposits of Lewis lung cancer cells
AKBULUT H., Tang Y., Akbulut K. G., Maynard J., Deisseroth A.
GENE THERAPY
, cilt.17, sa.11, ss.1333-1340, 2010 (SCI-Expanded, Scopus)
2010
201081. Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP
Dincol D., Buyukcelik A., Dogan M., AKBULUT H., Samur M., DEMİRKAZIK A., et al.
MEDICAL ONCOLOGY
, cilt.27, sa.3, ss.942-945, 2010 (SCI-Expanded, Scopus)
2010
201082. IgA lambda oligoclonal gammopathy in multiple myeloma
Tek I., Mizrak D., Utkan G., TOPRAK S. K., Tutkak H., Buyukcelik A., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.27, sa.2, ss.126-127, 2010 (SCI-Expanded, Scopus, TRDizin)
2010
201083. The effects of chemotherapeutic drugs on VEGF secretion of solid tumours
AKBULUT H., Aktas S. H., Ozal G., Zengin N., Akgun N., Ustuner Z., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.28, sa.15, 2010 (SCI-Expanded, Scopus)
2010
201084. Vector prime protein boost vaccination in the setting of myeloablative-induced lymphopenia suppresses growth of leukemia and solid tumors
Han T. H., Tang Y., Park Y. H., Maynard J., Li P., AKBULUT H., et al.
BONE MARROW TRANSPLANTATION
, cilt.45, sa.3, ss.550-557, 2010 (SCI-Expanded, Scopus)
2010
201085. The Prognostic Importance of Leucocytosis, Thrombocytosis and Serum Vascular Endothelial Growth Factor (VEGF) Level in Inoperable Non-Small Cell Lung Cancer (NSCLC): A Match-Pair Analysis
DEMİRKAZIK A., Asik M., Yalcin B., Dogan M., Buyukcelik A., Sencan O., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.20, sa.1, ss.14-19, 2010 (SCI-Expanded, Scopus, TRDizin)
2010
201086. Modification and implementation of NCCN guidelines on colon cancer in the Middle East and North Africa region.
Içli F., AKBULUT H., Bazarbashi S., Kuzu M. A., Mallath M. K., Rasul K. I., et al.
Journal of the National Comprehensive Cancer Network : JNCCN
, cilt.8 Suppl 3, 2010 (SCI-Expanded, Scopus)
2009
200987. The role of melatonin on gastric mucosal cell proliferation and telomerase activity in ageing
AKBULUT K. G., Gonul B., AKBULUT H.
JOURNAL OF PINEAL RESEARCH
, cilt.47, sa.4, ss.308-312, 2009 (SCI-Expanded, Scopus)
2009
200988. Vector vaccination and vector targeted chemotherapy in solid tumors
AKBULUT H., Tang Y., Deisseroth A.
Journal of B.U.ON.
, cilt.14, sa.SUPPL.1, 2009 (SCI-Expanded, Scopus)
2009
200989. COST-EFFECTIVENESS OF SORAFENIB IN UNRESECTABLE AND/OR METASTATIC RENAL CELL CARCINOMA IN TURKEY
Tatar M., AKBULUT H.
VALUE IN HEALTH
, cilt.12, sa.7, 2009 (SCI-Expanded, SSCI, Scopus)
2009
200990. Vector vaccination and vector targeted chemotherapy in solid tumors
AKBULUT H., Tang Y., Deisseroth A.
JOURNAL OF BUON
, cilt.14, 2009 (SCI-Expanded, Scopus)
2009
200991. Mutation profile of Turkish gastrointestinal stromal tumor cases: a multicenter study
Kaygusuz G., Suner S., Karatayli E., Bulbul D. G., Ozoran Y., AKBULUT H., et al.
VIRCHOWS ARCHIV
, cilt.455, ss.57, 2009 (SCI-Expanded, Scopus)
2009
200992. Effects of oxaliplatin and 5-fluorouracil on the healing of colon anastomoses
ERSOY P. E., AKBULUT H., Moray G.
SURGERY TODAY
, cilt.39, sa.1, ss.38-43, 2009 (SCI-Expanded, Scopus)
2009
200993. Kolon kanserinde gen tedavisi
BAYDIN P., AKBULUT H.
Türkiye Klinikleri Tıbbi Onkoloji
, cilt.2, sa.1, ss.83-90, 2009 (Hakemli Dergi)
2008
200894. Breast cancer with diabetes insipidus
DOĞAN M. K., Karakilic E., Oz I., ZORLU A. F., AKBULUT H.
Experimental Oncology
, cilt.30, sa.4, ss.324-326, 2008 (SCI-Expanded, Scopus)
2008
200895. Chemotherapy targeted to cancer tissue potentiates antigen-specific immune response induced by vaccine for in vivo antigen loading and activation of dendritic cells
AKBULUT H., Tang Y., AKBULUT K. G., Albert J. M., Deisseroth A.
MOLECULAR THERAPY
, cilt.16, sa.10, ss.1753-1760, 2008 (SCI-Expanded, Scopus)
2008
200896. Exogenous melatonin decreases age-induced lipid peroxidation in the brain
AKBULUT K. G., Gonul B., AKBULUT H.
BRAIN RESEARCH
, cilt.1238, ss.31-35, 2008 (SCI-Expanded, Scopus)
2008
200897. The impact of operation center and the prognostic factors on the outcome of patients with stage II and stage III colorectal cancer
Buyukqeljk A., AKBULUT H., Yalqin B., Encan O., Tek J., Demir O., et al.
Turkish Journal of Cancer
, cilt.38, sa.4, ss.175-183, 2008 (Scopus)
2008
200898. Combination of vaccine with targeted chemotherapy reduced levels of CSC like (CD44(+)CD24(-) hematopoietic lineage negative {LIN-}) cells and improves outcome of cancer treatment
AKBULUT H., Tang Y., Akbulut K. G., Maynard J., Deisseroth A. B.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.26, sa.15, 2008 (SCI-Expanded, Scopus)
2008
200899. Prognostic significance of serum matrix metalloproteinase 9 (MMP-9) levels in patients with sarcomas
Yaman E., Yalcin B., Utkan G., AKBULUT H., Isikdogan A., Sencan O., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.18, sa.2, ss.79-84, 2008 (SCI-Expanded, Scopus, TRDizin)
2008
2008100. The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma.
Sencan O., Buyukcelik A., Yalcin B., Boruban M. C., AKBULUT H., DEMİRKAZIK A., et al.
European journal of cancer care
, cilt.17, sa.1, ss.26-32, 2008 (SCI-Expanded, Scopus)
2007
2007101. Alveolar adenoma of the lung
SAK S., KÖSEOĞLU R. D., Demirag F., AKBULUT H., Gungor A.
APMIS
, cilt.115, sa.12, ss.1443-1449, 2007 (SCI-Expanded, Scopus)
2007
2007102. Symptoms or signs due to different chemotherapeutics and their relationship with serum cytokines/VEGF levels in patients with cancer
DEMİRKAZIK A., Yilmaz H., AKBULUT H., Yalcin B., Icli F.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.25, sa.18, 2007 (SCI-Expanded, Scopus)
2007
2007103. Donor lymphocyte infusions from Ad-sig-TAA/ecdCD40L vector prime-TAA/ecdCD40L protein boost (VPP) vaccinated allodonors decrease tumor cell growth post allograft
Deisseroth A. B., Tang Y., AKBULUT H., Maynard J., Petersen L.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.25, sa.18, 2007 (SCI-Expanded, Scopus)
2007
2007104. Opinions of the Turkish population on cancer and being informed for the diagnosis of cancer: An opinion survey
Yalcin B., Yalcin S., Buyukcelik A., Sencan O., Dogan M., Turk M., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.25, sa.18, 2007 (SCI-Expanded, Scopus)
2007
2007105. Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer
Icli F., AKBULUT H., Utkan G., Yalcin B., Dincol D., Isikdogan A., et al.
JOURNAL OF SURGICAL ONCOLOGY
, cilt.95, sa.6, ss.507-512, 2007 (SCI-Expanded, Scopus)
2007
2007106. Vaccine for Cancer and Infectious Diseases
Deisseroth A. B., Tang Y., AKBULUT H., Maynard J., Pedersen L.
JOURNAL OF IMMUNOLOGY
, cilt.178, 2007 (SCI-Expanded, Scopus)
2006
2006107. Hepatitis B and C seroprevalence in cancer patients: A case control study Kanserli hastalarda hepatit B ve C sikliǧi: Vaka kontrol çalişmasi
Utkan G., AZAP A., Muallaoǧlu S., Tokluoǧlu S., Durnali A. G., Arslan Ü. Y., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
, cilt.16, sa.3, ss.103-107, 2006 (SCI-Expanded, Scopus, TRDizin)
2006
2006108. The effect of venous thromboembolism on survival of cancer patients and its relationship with serum levels of factor VIII and vascular endothelial growth factor: a prospective matched-paired study
Dogan M., Demirkazik A., Konuk N., Yalcin B., Buyukcelik A., Utkan G., et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
, cilt.21, sa.4, ss.206-210, 2006 (SCI-Expanded, Scopus)
2006
2006109. Vector prime/protein boost vaccine that overcomes defects acquired during aging and cancer
Tang Y., AKBULUT H., Maynard J., Petersen L., Fang X., Zhang W., et al.
JOURNAL OF IMMUNOLOGY
, cilt.177, sa.8, ss.5697-5707, 2006 (SCI-Expanded, Scopus)
2006
2006110. Divided dose of cisplatin combined with gemcitabine in malignant mesothelioma.
Utkan G., Bueyuekcelik A., Yalcin B., AKBULUT H., DEMİRKAZIK A., Dincol D., et al.
Lung cancer (Amsterdam, Netherlands)
, cilt.53, sa.3, ss.367-74, 2006 (SCI-Expanded, Scopus)
2006
2006111. Thrombosis of the pulmonary artery in a patient with mucinous adenocarcinoma
Buyukcelik A., Yalcin B., Utkan G., Icli F., Sanlidilek U., AKBULUT H.
MEDICAL SCIENCE MONITOR
, cilt.12, sa.9, 2006 (SCI-Expanded, Scopus)
2006
2006112. Antitumor immune response induced by i.t. injection of vector-activated dendritic cells and chemotherapy suppresses metastatic breast cancer
AKBULUT H., Tang Y., Akbulut K. G., Maynard J., Zhang L., Deisseroth A.
MOLECULAR CANCER THERAPEUTICS
, cilt.5, sa.8, ss.1975-1985, 2006 (SCI-Expanded, Scopus)
2006
2006113. The clinical and pathological features of patients with gastric cancer in Turkey: A Turkish Oncology Group Study
Yalçin B., Zengin N., AYDIN F., Ilhan M., Işikdoǧan A., Demir G., et al.
Turkish Journal of Cancer
, cilt.36, sa.3, ss.108-115, 2006 (Scopus)
2006
2006114. Engineering conditionally replication-competent adenoviral vectors carrying the cytosine deaminase gene increases the infectivity and therapeutic effect for breast cancer gene therapy
Liu Y., Ye T., Maynard J., AKBULUT H., Deisseroth A.
CANCER GENE THERAPY
, cilt.13, sa.4, ss.346-356, 2006 (SCI-Expanded, Scopus)
2005
2005115. The efficacy of preoperative cisplatin and 5-flourouracil combination in patients with stage III squamous cell carcinoma of the esophagus
Han S., Yalçin B., AKBULUT H., Ökten I.
Turkish Journal of Cancer
, cilt.35, sa.1, ss.26-31, 2005 (Scopus)
2005
2005116. Frequency of symptoms in patients with advanced cancer
Yalçin B., Büyükçelik A., Şenler F. Ç., UTKAN G., Tek I., Doǧan M., et al.
Turkish Journal of Cancer
, cilt.35, sa.4, ss.177-180, 2005 (Scopus)
2005
2005117. DNA analysis and DNA ploidy in gastric cancer and gastric precancerous lesions
Yasa M., Bektas A., Yukselen V., AKBULUT H., Camci C., Ormeci N.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
, cilt.59, sa.9, ss.1029-1033, 2005 (SCI-Expanded, Scopus)
2005
2005118. Expression of P53 protein and DNA flow cytometry in gastric adenocarcinoma: Implications in patients treated with adjuvant etoposide, adriamycin and cisplatin
Buyukcelik A., Onur H., AKBULUT H., Yalcin B., ENSARİ A., Utkan G., et al.
TUMORI JOURNAL
, cilt.91, sa.4, ss.302-308, 2005 (SCI-Expanded, Scopus)
2005
2005119. Lymphoscintigraphy in pregnant patients with breast cancer: is it really safe?
Tek I., Buyukcelik A., Yalcin B., AKBULUT H.
ANNALS OF ONCOLOGY
, cilt.16, sa.4, ss.674, 2005 (SCI-Expanded, Scopus)
2005
2005120. Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III trial of Turkish Oncology Group.
Icli F., AKBULUT H., Uner A., Yalcin B., Baltali E., Altinbas M., et al.
British journal of cancer
, cilt.92, sa.4, ss.639-44, 2005 (SCI-Expanded, Scopus)
2005
2005121. Frequency of symptoms in patients with advanced cancer
YALÇIN B., ABDULLAH B., ÇAY ŞENLER F., UTKAN G., TEK İ., DOĞAN M., et al.
Turkish Journal of Cancer
, cilt.35, sa.4, ss.177-180, 2005 (Scopus)
2004
2004122. High-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas
Yalcin B., Pamir A., Buyukcelik A., Utkan G., Abulut H., Demirkazik A., et al.
EXPERIMENTAL ONCOLOGY
, cilt.26, sa.4, ss.320-325, 2004 (SCI-Expanded, Scopus)
2004
2004123. Vector targeting makes 5-fluorouracil chemotherapy less toxic and more effective in animal models of epithelial neoplasms
AKBULUT H., Tang Y., Maynard J., Zhang L., Pizzorno G., Deisseroth A.
CLINICAL CANCER RESEARCH
, cilt.10, sa.22, ss.7738-7746, 2004 (SCI-Expanded, Scopus)
2004
2004124. Overdose of lomustine: Report of two cases
Buyukcelik A., Akbulut H., Yalcin B., Ozdemir F., Icli F.
TUMORI JOURNAL
, cilt.90, sa.6, ss.628-629, 2004 (SCI-Expanded, Scopus)
2004
2004125. Serum vascular endothelial growth factor levels in patients with nonsmall, cell lung cancer
DEMİRKAZIK A., AKBULUT H., Ulger A., Arican A., Ozer I., Acikgoz N., et al.
ANNALS OF SAUDI MEDICINE
, cilt.24, sa.6, ss.473-475, 2004 (SCI-Expanded, Scopus)
2004
2004126. Multistep process through which adenoviral vector vaccine overcomes anergy to tumor-associated antigens
Tang Y., Zhang L., Yuan J., AKBULUT H., Maynard J., Linton P., et al.
BLOOD
, cilt.104, sa.9, ss.2704-2713, 2004 (SCI-Expanded, Scopus)
2004
2004127. The effects of chronomodulated therapy with 5-fluorouracil (5-Fu) and folinic acid (Fa) on the toxicity and quality of life in patients with advanced gastric cancer
Yalcin B., AKBULUT H., Buyukcelik A., Sencan O., Demirkazik A., Onur H., et al.
BIOLOGICAL RHYTHM RESEARCH
, cilt.35, sa.4-5, ss.259-268, 2004 (SCI-Expanded, Scopus)
2004
2004128. The opinions of the cancer patients about pain management A questionnaire study
YALÇIN B., ÇAY ŞENLER F., BÜYÜKÇELİK A., UTKAN G., TEK İ., DORUK H., et al.
Turkish Journal of Cancer 34(3):114-117 · July 2004
, cilt.34, sa.3, ss.114-117, 2004 (Scopus)
2004
2004129. The opinions of the cancer patients about pain management: A questionnaire study
Yalçin B., Şenler F. Ç., Büyükçelik A., UTKAN G., Tek I., Doruk H., et al.
Turkish Journal of Cancer
, cilt.34, sa.3, ss.114-117, 2004 (Scopus)
2004
2004130. Activity of irinotecan, cisplatin and dacarbazine (CPD) combination in previously treated patients with advanced colorectal carcinoma
AKBULUT H., Icli F., Yalcin B., DEMİRKAZIK A., Onur H., Buyukcelik A., et al.
EXPERIMENTAL ONCOLOGY
, cilt.26, sa.2, ss.149-152, 2004 (SCI-Expanded, Scopus)
2004
2004131. Thromboembolism in patients with cancer
Büyükçelik A., AKBULUT H.
Turkish Journal of Haematology
, cilt.21, sa.1, ss.7-11, 2004 (SCI-Expanded, Scopus)
2004
2004132. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies
Idilman R., Arat M., Soydan E., TÖRÜNER M., Soykan I., Akbulut H., et al.
JOURNAL OF VIRAL HEPATITIS
, cilt.11, sa.2, ss.141-147, 2004 (SCI-Expanded, Scopus)
2004
2004133. A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study
Yalcin B., ÜNER A., AKBULUT H., Icli F., Buyukcelik A., Isikdogan A., et al.
ANNALS OF ONCOLOGY
, cilt.15, ss.42, 2004 (SCI-Expanded, Scopus)
2004
2004134. The prognostic Importance of Venous Thromboembolism (VT) in cancer patients and its relationship with the ieveis of factor VIII and Vascular Endothelial Growth Factor (VEGF)
DEMİRKAZIK A., Dogan M., Konuk N., AKBULUT H., Yalcin B., Buyukcelik A., et al.
ANNALS OF ONCOLOGY
, cilt.15, ss.151, 2004 (SCI-Expanded, Scopus)
2003
2003135. An adenoviral vector cancer vaccine that delivers a tumor-associated antigen/CD40-ligand fusion protein to dendritic cells
Zhang L., Tang Y., AKBULUT H., Zelterman D., Linton P., Deisseroth A.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
, cilt.100, sa.25, ss.15101-15106, 2003 (SCI-Expanded, Scopus)
2003
2003136. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon
AKBULUT H., Zhang L., Tang Y., Deisseroth A.
CANCER GENE THERAPY
, cilt.10, sa.5, ss.388-395, 2003 (SCI-Expanded, Scopus)
2003
2003137. Daily variations of plasma malondialdehyde levels in patients with early breast cancer
Akbulut H., Akbulut K., Icli F., Buyukcelik A.
CANCER DETECTION AND PREVENTION
, cilt.27, sa.2, ss.122-126, 2003 (SCI-Expanded, Scopus)
2002
2002138. Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma.
Akbulut H., ALTUNTAŞ F., Akbulut K., Ozturk G., Cindoruk M., Unal E., et al.
Cytokine
, cilt.20, sa.4, ss.184-90, 2002 (SCI-Expanded, Scopus)
2002
2002139. Adenoviral vectors with E1A regulated by tumor-specific promoters are selectively cytolytic for breast cancer and melanoma
Zhang L., AKBULUT H., Tang Y., Peng X., Pizzorno G., Sapi E., et al.
MOLECULAR THERAPY
, cilt.6, sa.3, ss.386-393, 2002 (SCI-Expanded, Scopus)
2002
2002140. Effect of granulocyte-macrophage colony-stimulating factor on hepatic regeneration after 70% hepatectomy in normal and cirrhotic rats
EROĞLU A. H., DEMİRCİ S., AKBULUT H., Sever N., DEMİRER S., ÜNAL A. E.
HPB
, cilt.4, sa.2, ss.67-73, 2002 (SCI-Expanded, Scopus)
2001
2001141. Radiation recall effect with docetaxel: Is it a barrier for sandwich approach of radiotherapy sequencing in adjuvant breast cancer treatment?
Samur M., Garipaǧaoǧlu M., AKBULUT H.
Turkish Journal of Cancer
, cilt.31, sa.2, ss.82-86, 2001 (Scopus, TRDizin)
2001
2001142. Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma
Emri S., AKBULUT H., Zorlu F., Dincol D., Akay H., Gungen Y., et al.
LUNG CANCER
, cilt.33, sa.2-3, ss.109-114, 2001 (SCI-Expanded, Scopus)
2001
2001143. A randomized trial of four cycles of adjuvant AC (adriamycin plus cyclophosphamide) +/- two cycles of EP (etoposide plus cisplatin) in node positive patients with breast cancer
Icli F., AKBULUT H., Dincol D., Onur H., DEMİRKAZIK A., Cam R., et al.
ANNALS OF ONCOLOGY
, cilt.12, sa.7, ss.1011-1013, 2001 (SCI-Expanded, Scopus)
2001
2001144. The effects of melatonin on humoral immune responses of young and aged rats
Akbulut K., Gonul B., Akbulut H.
IMMUNOLOGICAL INVESTIGATIONS
, cilt.30, sa.1, ss.17-20, 2001 (SCI-Expanded, Scopus)
2000
2000145. Overdosage of pamidronate in a patient with renal cell carcinoma
AKBULUT H., Icli F.
MEDICAL ONCOLOGY
, cilt.17, sa.4, ss.340-341, 2000 (SCI-Expanded, Scopus)
2000
2000146. Diurnal variations of serum GM-CSF levels
Dincol D., Akbulut H., Buyukcelik A., Icli F.
CYTOKINE
, cilt.12, sa.7, ss.1151-1155, 2000 (SCI-Expanded, Scopus)
2000
2000147. Prospective randomized comparison of morning versus night daily single subcutaneous administration of granulocyte-macrophage-colony stimulating factor in patients with soft tissue or bone sarcoma
Dincol D., Samur M., Pamir A., Sencan O., Akbulut H., Yalcin B., et al.
CANCER
, cilt.88, sa.9, ss.2033-2036, 2000 (SCI-Expanded, Scopus)
2000
2000148. The efficacy of irinotecan, cisplatin and dacarbazine combination in patients with metastatic colorectal cancer resistant to 5-fluorouracil.
AKBULUT H., Icli F., DEMİRKAZIK A., Yalcin B., Buyukcelik A., Cay F.
ANNALS OF ONCOLOGY
, cilt.11, ss.46, 2000 (SCI-Expanded, Scopus)
2000
2000149. Comparison of 5-fluorouracil-folinic acid and etoposide-doxorubicin-cisplatin chemotherapies in patients with advanced gastric carcinoma: A prospective randomized crossover study, interim analysis.
Sencan O., DEMİRKAZIK A., AKBULUT H., Yalcin B., Icli F.
ANNALS OF ONCOLOGY
, cilt.11, ss.70-71, 2000 (SCI-Expanded, Scopus)
1999
1999150. Clinicopathologic features and prognostic factors of primary extranodal non-Hodgkin's lymphomas in Turkey
Arican A., Dincol D., Akbulut H., Onur H., DEMİRKAZIK A., Cay F., et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
, cilt.22, sa.6, ss.587-592, 1999 (SCI-Expanded, Scopus)
1999
1999151. Serum "Vascular Endothelial Growth Factor" (VEGF) levels in patients with non-small cell lung cancer (NSCLC)
Demirkazik A., Ozer I., Akbulut H., Arican A., Kulah E., Acikgoz N., et al.
EUROPEAN JOURNAL OF CANCER
, cilt.35, 1999 (SCI-Expanded, Scopus)
1999
1999152. Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer
Eroglu A., Demirci S., Ayyildiz A., Kocaoglu H., Akbulut H., Akgul H., et al.
BRITISH JOURNAL OF CANCER
, cilt.80, sa.10, ss.1630-1634, 1999 (SCI-Expanded, Scopus)
1999
1999153. Differential effects of pharmacological doses of melatonin on malondialdehyde and glutathione levels in young and old rats
Akbulut K., Gonul B., Akbulut H.
GERONTOLOGY
, cilt.45, sa.2, ss.67-71, 1999 (SCI-Expanded, Scopus)
1999
1999154. Cardiotoxicity of 5-fluorouracil: Two cases with severe bradycardia and review of the literature
Samur M., Arican A., Cakir M., Sencan O., DEMİRKAZIK A., AKBULUT H., et al.
Turkish Journal of Cancer
, cilt.29, sa.1, ss.39-41, 1999 (Scopus, TRDizin)
1999
1999155. The role of granulocyte-macrophage-colony stimulating factor, cortisol, and melatonin in the regulation of the circadian rhythms of peripheral blood cells in healthy volunteers and patients with breast cancer
Akbulut H., Icli F., Buyukcelik A., Akbulut K., Demirci S.
JOURNAL OF PINEAL RESEARCH
, cilt.26, sa.1, ss.1-8, 1999 (SCI-Expanded, Scopus)
1999
1999156. Relationship between serum concentration of vascular endothelial growth factor and tumor stage in breast cancer patients
Eroglu A., Demirkazik A., AKBULUT H., Eroglu N.
Journal of B.U.ON.
, cilt.4, sa.1, ss.83-85, 1999 (Scopus)
1999
1999157. The clinical value of flow cytometric DNA content analysis in patients with soft tissue sarcomas
Samur M., Pamir A., AKBULUT H., Erekul S., Saǧlik Y., YILDIZ Y., et al.
Sarcoma
, cilt.3, sa.3-4, ss.171-175, 1999 (Scopus)
1999
1999158. The effect of two different doses of oral clodronate on pain in patients with bone metastases
Arican A., Içli F., AKBULUT H., Çakir M., Sencan O., Samur M., et al.
MEDICAL ONCOLOGY
, cilt.16, sa.3, ss.204-210, 1999 (SCI-Expanded, Scopus)
1999
1999159. Phase II study of cisplatin and dacarbazine for metastatic colorectal carcinoma resistant to 5-fluorouracil
Icli F., Arican A., Cay F., AKBULUT H., Dincol D., Karaoguz H., et al.
ONCOLOGY
, cilt.56, sa.4, ss.297-300, 1999 (SCI-Expanded, Scopus)
1998
1998160. A randomized phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma
Icli F., ÇELİK İ., Aykan F., Uner A., DEMİRKAZIK A., Ozet A., et al.
CANCER
, cilt.83, sa.12, ss.2475-2480, 1998 (SCI-Expanded, Scopus)
1998
1998161. Prognostic factors in patients with recurrent breast cancer following mastectomy
Icli F., Cay F., Dincol D., Karaoguz H., Demirkazik A., Akbulut H.
EUROPEAN JOURNAL OF CANCER
, cilt.34, 1998 (SCI-Expanded, Scopus)
1998
1998162. The effect of two different doses of oral clodronate on pain in patients with bone metastases
Ancan A., Icli F., Akbulut H., Cakr M., Sencan O., Samur M., et al.
EUROPEAN JOURNAL OF CANCER
, cilt.34, 1998 (SCI-Expanded, Scopus)
1998
1998163. A comparison of imipenem monotherapy versus cefoperazone/sulbactam plus amikacin combination treatment in febrile neutropenic cancer patients
Dincol D., Arican A., Aydin F., Samur M., Willke A., AKBULUT H., et al.
CANCER JOURNAL - FRANCE
, cilt.11, sa.2, ss.89-93, 1998 (SCI-Expanded, Scopus)
1998
1998164. Cisplatin and epirubicin induction chemotherapy followed by chemoradiotherapy in limited stage small cell lung cancer (LS-SCLC)
Cay F., Onat H., Saip P., Kars A., DEMİRKAZIK A., AKBULUT H., et al.
ANNALS OF ONCOLOGY
, cilt.9, ss.104, 1998 (SCI-Expanded, Scopus)
1998
1998165. The prognostic significance of flow cytometric cellular DNA content determination in patients with colorectal carcinoma
AKBULUT H., Dincol D., Aydintug O., Icli F., Karaoguz H., DEMİRKAZIK A., et al.
Turkish Journal of Cancer
, cilt.28, sa.2, ss.51-58, 1998 (Scopus, TRDizin)
1998
1998166. Surgical resection followed by adjuvant chemotherapy in small cell lung cancer with limited disease
Arican A., Dincol D., AKBULUT H., Cay F., Icli F., Karaoguz H., et al.
ANNALS OF ONCOLOGY
, cilt.9, ss.105-106, 1998 (SCI-Expanded, Scopus)
1998
1998167. Myeloprotective effect of high dose medroxyprogesterone acetate on patients receiving cytotoxic chemotherapy
Samur M., Icli F., AKBULUT H., DEMİRKAZIK A., Cay F., Arican A.
Turkish Journal of Cancer
, cilt.28, sa.3, ss.118-123, 1998 (Scopus, TRDizin)
1998
1998168. Effects of high dose medroxyprogesterone acetate on endogenous granulocyte macrophage-colony stimulating factor secretion and bone marrow cellularity in patients under cytotoxic chemotherapy
AYDİN F., DEMİRKAZIK A., Içli F., AKBULUT H., Samur M.
Journal of Chemotherapy
, cilt.10, sa.5, ss.394-398, 1998 (SCI-Expanded, Scopus)
1997
1997169. Cost-effectiveness of radionuclide bone scanning to rule out asymptomatic bone metastases in clinically operable non-small cell lung cancer
Arican A., Dincol D., Samur M., Demirkazlk A., Sencan O., Akbulut H., et al.
EUROPEAN JOURNAL OF CANCER
, cilt.33, 1997 (SCI-Expanded, Scopus)
1997
1997170. Results of the cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP)+/-bleomycin treatment and evaluation of prognostic factors in aggressive lymphomas in Turkey
Dincol D., AKBULUT H., Icli F., Samur M., Karaoguz H., DEMİRKAZIK A., et al.
ONCOLOGY
, cilt.54, sa.5, ss.376-379, 1997 (SCI-Expanded, Scopus)
1997
1997171. Comparative study of imipenem versus sulperazone plus amikacin in febrile neutropenia
Dincol D., Arican A., Aydin F., Samur M., Willke A., Akbulut H., et al.
EUROPEAN JOURNAL OF CANCER
, cilt.33, ss.253, 1997 (SCI-Expanded, Scopus)
1997
1997172. Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease - A Turkish experience
Akbulut H., Soykan I., Yakaryilmaz F., Icli F., Aksoy F., Haznedaroglu S., et al.
CANCER
, cilt.80, sa.1, ss.8-14, 1997 (SCI-Expanded, Scopus)
1997
1997173. Malondialdehyde and glutathione in rat gastric mucosa and effects of exogenous melatonin
Akbulut H., Akbulut K., Gonul B.
DIGESTIVE DISEASES AND SCIENCES
, cilt.42, sa.7, ss.1381-1382, 1997 (SCI-Expanded, Scopus)
1997
1997174. Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric
Icli F., Karaoguz H., AKBULUT H., Dincol D., DEMİRKAZIK A., Cay F.
JOURNAL OF SURGICAL ONCOLOGY
, cilt.64, sa.4, ss.318-323, 1997 (SCI-Expanded, Scopus)
1996
1996175. Two dose levels of ifosfamide in malignant mesothelioma
Icli F., Karaoguz H., Hasturk S., Kurt B., AKBULUT H., Dincol D., et al.
LUNG CANCER
, cilt.15, sa.2, ss.207-213, 1996 (SCI-Expanded, Scopus)
1996
1996176. Serum and tissue zinc concentrations in patients with duodenal ulcers DUODENUM ULSERLI HASTALARDA SERUM VE DOKU CINKO DUZEYLERI
Soykan I., AKBULUT H., YILDIRIM İ. E., Haznedaroglu S.
Turkish Journal of Gastroenterology
, cilt.7, sa.1, ss.53-56, 1996 (SCI-Expanded, Scopus, TRDizin)
1995
1995177. Results of the cyclophosphamide, adriamycine, vincristine, prednisolon (CHOP) +/- bleomycine treatment and evaluation of prognostic factors in aggressive lymphomas
Dincol D., Icli F., Akbulut H., Samur M., Karaoguz H., Demirkazik A., et al.
EUROPEAN JOURNAL OF CANCER
, cilt.31A, ss.784, 1995 (SCI-Expanded, Scopus)
1995
1995178. MESNA IFOSFAMIDE, MITOXANTRONE, ETOPOSIDE, BLEOMYCIN, VINCRISTINE, PREDNISONE (MINE-BOP) COMBINATION CHEMOTHERAPY IN THE TREATMENT OF REFRACTORY AND RELAPSED NON-HODGKINS-LYMPHOMA
DINCOL D., ICLI F., KARAOGUZ H., CAY F., ARICAN A., DEMİRKAZIK A., et al.
ACTA ONCOLOGICA
, cilt.34, sa.7, ss.937-940, 1995 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2024
20241. Kanser tedavisinde kullanılmak üzere anti_CD47 scFv gen tedavi vektörleri geliştirilmesi
SONUGÜR F. G., Korgan E., BABAHAN C., AKBULUT H.
9. Karadeniz Onkoloji Günleri, Trabzon, Türkiye, 17 - 19 Ekim 2024, (Özet Bildiri)
2024
20242. Increased Expression of DNA Damage Inducible Transcript 4 Gene is Associated with Poor Prognosis and “Right-Sidedness” in Colorectal Cancer
demir f. g., TAMAM S., ÇULCU S., SAVAŞ B., AKBULUT H., ÖZDAĞ SEVGİLİ H., et al.
How to bring basic science discoveries to the clinic, 27 Şubat 2024, (Tam Metin Bildiri)
2023
20233. INHBA is a potential biomarker and therapeutic target for patients with colorectal cancer
BELDER N., DEMİRKOL CANLI S., TAMAM S., ÇULCU S., SAVAŞ B., AKBULUT H.
November 29 – December 02, 2023 9 th International BAU Drug Design Congress, 29 Kasım - 02 Aralık 2023, (Tam Metin Bildiri)
2023
20234. Replication Defective Adenoviral Vectors Decreases the Immunosuppresive Cytokine Expression in Tumor Cells
Zengin İ., SONUGÜR F. G., BABAHAN C., Abdi Abgarmi S., AKBULUT H.
BIO Türkiye Uluslararası Biyoteknoloji Kongresi, İstanbul, Türkiye, 28 Eylül 2023, (Özet Bildiri)
2023
20235. Replication Defective Adenoviral Vectors do not induce Apoptosis and Autophagy in endothelial cells
Korgan E., BABAHAN C., SONUGÜR F. G., Abdi Abgarmi S., AKBULUT H.
BIO Türkiye Uluslararası Biyoteknoloji Kongresi, İstanbul, Türkiye, 28 Eylül 2023, (Özet Bildiri)
2023
20236. Low-Dose Chemotherapy Inhibits Proangiogenic Factors in Endothelial and Cancer Cells
SONUGÜR F. G., BABAHAN C., AKBULUT H.
BIO Türkiye Uluslararası Biyoteknoloji Kongresi, İstanbul, Türkiye, 28 - 30 Eylül 2023, (Özet Bildiri)
2023
20237. Purification Optimization Of A Recombinant Single-Chain Variable Fragment (ScFv) Antibody
BABAHAN C., SONUGÜR F. G., KARAGÖZ Z., YILMAZ E., AKBULUT H.
BIOTürkiye, İstanbul, Türkiye, 28 - 30 Eylül 2023, (Tam Metin Bildiri)
2023
20238. Nadir Meme Kanseri Tipleri - Tek Merkez Deneyimi
YAŞAR H. A., KUBİLAY TOLUNAY P., AKBULUT H.
On Targed Master Oncology, Muğla, Türkiye, 21 - 24 Eylül 2023, ss.43-44, (Özet Bildiri)
2017
20179. GİST HASTALARINDA İMATİNİB ALTINDA KAN LİPİD DÜZEYİ DEĞİŞİKLİKLERİ
KÖKSOY E. B., KARCI E., ÜRÜN M., YAŞAR H. A., ÖZYURT N., UTKAN G., et al.
22. Ulusal Kanser Kongresi, Antalya, Türkiye, 19 - 23 Nisan 2017, ss.441, (Özet Bildiri)
2022
202210. DOWNSTREAM PROSES SÜRECİNDE İNKÜBASYON SICAKLIĞI VE MİKROFİLTRASYON MEMBRANI SEÇİMİNİN REKOMBİNANT ADENOVİRAL VEKTÖR VERİMİNE ETKİSİ
SONUGÜR F. G., BABAHAN C., Abdi Abgarmi S., AKBULUT H.
4.Uluslararası Aşı Bilimi Kongresi, Ankara, Türkiye, 03 Kasım 2022, cilt.1, ss.1, (Tam Metin Bildiri)
2022
202211. İLERİ EVRE MALİGNİTELERDE İMMÜNCHECKPOİNT İNHİBİTÖRLERİ İLE EŞ ZAMANLI VERİLEN ANTİHİSTAMİNİKLERİN SAĞKALIM KATKISI İLE İLGİLİ GERÇEK YAŞAM VERİLERİ
Eylemer Mocan E., Yekedüz E., Karataş G., Yazgan S. C., Köksoy E. B., Çay Şenler F., et al.
9. TÜRK TIBBİ ONKOLOJİ DERNEĞİ KONGRESİ, Girne, Kıbrıs (Kktc), 18 - 22 Mayıs 2022, ss.53-54, (Özet Bildiri)
2022
202212. Sirolimus Kemopreventif Tedavisi Altındaki Bir PTEN Hamartom Sendromu Olan Bannayan-Riley-Ruvalcaba Sendromu
Eylemer Mocan E., Köksoy E. B., Akbulut H.
9. Türk Tıbbi Onkoloji Derneği Kongresi , Girne, Kıbrıs (Kktc), 18 - 22 Mayıs 2022, ss.196, (Özet Bildiri)
2022
202213. İleri evre malignitelerde immüncheckpoint inhibitörleri ile eş zamanlı verilen antihistaminiklerin sağkalım katkısı ile ilgili gerçek yaşam verileri
EYLEMER MOCAN E., YEKEDÜZ E., KARATAŞ G., YAZGAN S. C., KÖKSOY E. B., ÇAY ŞENLER F., et al.
9. Türk Tıbbi Onkoloji Kongresi, Girne, Kıbrıs (Kktc), 18 - 22 Mayıs 2022, ss.53, (Özet Bildiri)
2022
202214. İmmünoterapi alan metastatik melanom hastalarında vücut kompozisyonu ve sağkalım arasındaki ilişkinin değerlendirilmesi
KARATAŞ G., YEKEDÜZ E., KİRİŞCİ B., ÇAY ŞENLER F., AKBULUT H.
9. Türk Tıbbi Onkoloji Kongresi, Girne, Kıbrıs (Kktc), 18 - 22 Mayıs 2022, ss.224, (Özet Bildiri)
2021
202115. CRP/albumin oranının immün denetim noktası inhibitörü alan metastatik kanser hastalarındaki prognostik rolü
YEKEDÜZ E., YAZGAN S. C., KÖKSOY E. B., AKBULUT H., ÇAY ŞENLER F., DEMİRKAZIK A., et al.
8. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 3 - 07 Kasım 2021, ss.108, (Özet Bildiri)
2021
202116. Regorafenib ile tedavi edilen nüks metastatik osteosarkom olgusu
DURSUN B., BALLI S., KALACI E., AKBIYIK I., YEKEDÜZ E., KAVAK E. E., et al.
8. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 3 - 07 Kasım 2021, ss.183-184, (Özet Bildiri)
2021
202117. Letrozol ilişkili mediastinal lenfadenopatiler ve pulmoner nodüller
KÖKSOY E. B., YEKEDÜZ E., KALACI E., AKBULUT H., DEMİRKAZIK A.
8. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 3 - 07 Kasım 2021, ss.161, (Özet Bildiri)
2020
202018. The impact of COVID-19 pandemic on cancer care: A global collaborative study
Jazieh A. R., AKBULUT H., Curigliano G., Rogado A., Alsharm A. A., Razis E., et al.
ESMO Virtual Congress, ELECTR NETWORK, 19 Eylül - 18 Ekim 2020, cilt.31, (Özet Bildiri)
2019
201919. The Effect of PD-L1 Expression on Angiogenesis and Invasion in Tumor Cells
BABAHAN C., Abdi Abgarmi S., SONUGÜR F. G., AKBULUT H.
Immuno-Oncology 2019, Barselona, İspanya, 23 Mayıs 2019, ss.6-7, (Özet Bildiri)
2019
201920. Oxidative Stress and Sirtuin2 Changes in Different Partsof the Brain in Aging: Protective Effect of Melatonin
AKBULUT K. G., KESKİN AKTAN A., Abgarmi S. A., AKBULUT H.
Turkish Society of Physiological Sciences 45th National Physiology Congress Kuşadası-Aydın, Türkiye, 31 Ekim - 03 Kasım 2019, (Özet Bildiri)
2019
201921. Meme Kanserinde Survivin İfadesinin Tamoksifen Direncine Etkisi
DEDE İ., AKBULUT H., KARABÖRK A., ÇETİN Ş.
4th International Symposium on Innovative Approaches in Health and Sports Sciences Proceedings, 22 - 24 Kasım 2019, (Tam Metin Bildiri)
2019
201922. The role of pericytes on the efficacy of Bevacizumab in colorectalcancer
Bakırcı M., dost günay f. s., ÇAY ŞENLER F., kırmızı a. b., SAVAŞ B., AKBULUT H.
7th International Congress of Molecular Medicine, 5 - 07 Eylül 2019, (Özet Bildiri)
2019
201923. The role of pericytes on the efficacy of Bevacizumab in colorectal cancer
Besler M., Dost Günay F. S., ÇAY ŞENLER F., KIRMIZI B. A., SAVAŞ B., AKBULUT H.
VII. International Congress of Molecular Medicine, 5 - 07 Eylül 2019, (Özet Bildiri)
2019
201924. Anti-Angiogenic Treatment Suppresses the Immunosuppressive Cytokine Production in Tumor Cells
Abdi Abgarmi S., BABAHAN C., SONUGÜR F. G., AKBULUT H.
Immuno-Oncology 2019, Barselona, İspanya, 23 Mayıs 2019, (Özet Bildiri)
2019
201925. Setüksimab tedavisi ile uzun süre stabil seyretmiş cilt SCC olgusu
ÖZYURT N., GÜRBÜZ M., YAŞAR H. A., KUBİLAY TOLUNAY P., YEKEDÜZ E., KARAALİOĞLU B., et al.
23. Ulusal Kanser Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2019, ss.401, (Özet Bildiri)
2019
201926. Nodüler Lenfosit Baskın Hodgkin Lymphoma (NLBHL)’da Kombine İnflamasyon İndeksinin Prognostik Önemi
PAYDAŞ S., ÇAKAR M. K., BARIŞTA İ., SEYDAOĞLU G., PEHLİVAN M., DOĞAN M., et al.
23. Ulusal Kanser Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2019, (Özet Bildiri)
2019
201927. Nazofarenks Kanserli Hastalarda Sağkalım İle İlişkili Prognostik Faktörler
YAŞAR H. A., KUBİLAY TOLUNAY P., DEMİRKIRAN A., KARAAĞAÇ M., GÜMÜŞTEPE E., UTKAN G., et al.
23. Ulusal Kanser Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2019, (Özet Bildiri)
2019
201928. Kastrasyon Dirençli Metastatik Prostat Kanseri (Kdmpk) Olan Geriatrik (≥75 Yaş) Hastalarda 1. Basamak Dosetaksel Tedavi Sonuçları- Gerçek Yaşam Verisi
ALKAN A., Sevgen Güç Z., GÜRBÜZ M., Özgün G., DEĞİRMENCİOĞLU S., Doğan M., et al.
23. Ulusal Kanser Kongresi - 2019, Türkiye, 17 - 21 Nisan 2019, (Özet Bildiri)
2019
201929. GERİATRİK (≥75 YAŞ), KASTRASYON DİRENÇLİMETASTATİK PROSTAT KANSERİ (KDMPK)HASTALARINDA 1. BASAMAK ANTİ- ANDROJENTEDAVİ SONUÇLARI- GERÇEK YAŞAM VERİSİ
ALKAN A., SEVGEN GÜÇ Z., GÜRBÜZ M., ÖZGÜN G., DEĞİRMENCİOĞLU S., DOĞAN M., et al.
23. ULUSAL KANSER KONGRESİ, Antalya, Türkiye, 17 - 21 Nisan 2019, ss.300, (Özet Bildiri)
2019
201930. GERIATRIK (≥75 YAŞ), KASTRASYON DIRENÇLI METASTATIK PROSTAT KANSERI (KDMPK) HASTALARINDA 1. BASAMAK ANTI- ANDROJEN TEDAVI SONUÇLARI- GERÇEK YAŞAM VERISI
ALKAN A., Sevgen Güç Z., GÜRBÜZ M., Özgün G., DEĞİRMENCİOĞLU S., Doğan M., et al.
23. ULUSAL KANSER KONGRESİ - 2019, Türkiye, 17 - 21 Nisan 2019, (Tam Metin Bildiri)
2019
201931. Kastrasyon Dirençli Metastatik Prostat Kanseri (Kdmpk) Olan Geriatrik (≥75 Yaş) Hastalarda 1. Basamak Dosetaksel Tedavi Sonuçları- Gerçek Yaşam Verisi
ALKAN A., SEVGEN GÜÇ Z., GÜRBÜZ M., ÖZGÜN G., DEĞİRMENCİOĞLU S., DOĞAN M., et al.
23. ULUSAL KANSER KONGRESİ, Antalya, Türkiye, 17 - 21 Nisan 2019, ss.185, (Özet Bildiri)
2017
201732. Start of a new Arms Race? The US nuclear Arms Policy in the Trump era
AKBULUT H.
Conference on Radical Break?- American Foreign Policy in the Era of Donald Trump, Tutzing, Almanya, 15 - 17 Aralık 2017, cilt.15, ss.153-186, (Tam Metin Bildiri)
2018
201833. Neuroprotective Effects of Sirt2 Inhibition in Aging
KESKİN AKTAN A., AKBULUT K. G., AKBULUT H.
Turkish Society of Physiological Sciences 44, Antalya, Türkiye, 1 - 04 Kasım 2018, (Özet Bildiri)
2018
201834. Age-related changes in the oxidative stress, apoptosis,sirtuin 2 and FoxO3a expression in the hippocampus:protective effects of melatonin
KESKİN AKTAN A., Abgarmi S., AKBULUT K. G., AKBULUT H.
14-16 September 2018The QEII Centre, London, UK, 14 - 16 Eylül 2018, (Özet Bildiri)
2018
201835. SIRT2 inhibition suppresses the oxidative stress andapoptotic activity, and increases autophagy of cerebralcortex in the aging process.
AKBULUT K. G., KESKİN AKTAN A., Abgarmi S., AKBULUT H.
14-16 September 2018The QEII Centre, London, UK, Londrina, Brezilya, 14 - 16 Eylül 2018, (Özet Bildiri)
2018
201836. MIDE KANSERI VE ABO KAN GRUBU İLIŞKISI: ÇOK MERKEZLI, GÖZLEMSEL, VAKA-KONTROL ÇALIŞMASI
YAŞAR H. A., UTKAN G., ÖZDEMİR N., ÇAKMAK ÖKSÜZOĞLU Ö. B., DEDE İ., ÜRÜN Y., et al.
7. Türk Tıbbı Onkoloji Kongresi, Antalya, Türkiye, 21 - 25 Mart 2018, ss.443, (Özet Bildiri)
2018
201837. A bicistronic adenoviral vector carrying cytosine deaminase and GM-CSF genes significantly improves antitumor immunity and overall survival in colon cancer
AKBULUT H., ÇÖLERİ CİHAN A., ŞAHİN G., Tang Y., Deisseroth A., Icli F.
Annual Meeting of the American-Association-for-Cancer-Research (AACR), Illinois, Amerika Birleşik Devletleri, 14 - 18 Nisan 2018, cilt.78, (Özet Bildiri)
2018
201838. The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.
AKBULUT H., Öçal M., Sonugür F. G., Babahan C., Abdi Abgarmi S.
ASCO 2018, 1 - 04 Haziran 2018, (Özet Bildiri)
2018
201839. Pankreas Kanseri ve ABO Kan Grubu İliskisi: Çok Merkezli, Gözlemsel, Vaka-Kontrol Çalışması
KÖKSOY E. B., UTKAN G., ERGÜN Y., ESİN E., ŞENDUR M. A. N., KARCI GÜNER E., et al.
7. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 21 - 25 Mart 2018, (Özet Bildiri)
2018
201840. METASTATİK OLMAYAN KOLOREKTAL ADENOKANSERDE HASTALIKSIZ SAĞKALIM İLE İLGİLİ PREDİKTİF FAKTÖRLERİN DEĞERLENDİRİLMESİ
KARCI E., KÖKSOY E. B., HOCAZADE C., BİLGİN B., ALKAN A., YAŞAR H. A., et al.
7. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 21 - 25 Mart 2018, (Özet Bildiri)
2018
201841. İPILIMUMAB ILE TEDAVI EDILEN MUKOZAL VE UVEAL MALIGN MELANOM HASTALARINDA SAĞKALIM IÇIN PROGNOSTIK FAKTÖRLER: TÜRK ONKOLOJI ÇALIŞMA GRUBU (TOG) ÇALIŞMASI
YAŞAR H. A., TURNA Z. H., ESİN E., SEDEF A. M., ALKAN A., ÇAKMAK ÖKSÜZOĞLU Ö. B., et al.
7. Türk Tıbbı Onkoloji Kongresi, Antalya, Türkiye, 21 - 25 Mart 2018, ss.150, (Özet Bildiri)
2018
201842. Quality of life study in patients with unresectable locally advanced or metastatic pancreatic cancer treated with gemcitabine in combination with nab-paclitaxel versus gemcitabine alone:ax-panc-sy001: A phase II randomized study.
Yalcin S., Dane F., Oksuzoglu B., Yildirim N., Isikdogan A., Ozkan M., et al.
Gastrointestinal Cancers Symposium, San-Francisco, Kostarika, 18 - 20 Ocak 2018, cilt.36, (Özet Bildiri)
2017
201743. Relationship between metabolic parameters and ras mutation status
KARCI E., SOYDAL Ç., UTKAN G., ÜRÜN Y., AKBULUT H.
30th Annual Congress of the European Association of Nuclear Medicine, 21 - 25 Ekim 2017, cilt.44, ss.696, (Özet Bildiri)
2017
201744. Oxidative stress, FOXO3a andBIM expressions in aging cerebral cortex: modulation by curcumin
KESKİN AKTAN A., AKBULUT K. G., AKBULUT H.
2ndInternational Gazi Pharma Symposium Series (GPSS-2017), October 11-13, 2017, GaziUniversity, Turkey. P, 11 - 13 Ekim 2017, (Özet Bildiri)
2017
201745. The effects of curcumin administration on hippocampal SIRT2 , BCL-2 BAX and BIM expression in young and aged rats.
KESKİN AKTAN A., AKBULUT K. G., AKBULUT H.
43. Ulusal Fizyoloji Kongresi, Türkiye, 7 - 09 Eylül 2017, (Özet Bildiri)
2017
201746. Significance of tumour-infiltrating lymphocytes (TILs) in gastric carcinomas: Association of PD-L1 and PD-1 expression with prognostic parameters and survival
Arman F., YAŞAR H. A., SAVAŞ B., AKBULUT H., ENSARİ A.
European Congress of Pathology, 2 - 06 Eylül 2017, cilt.471, ss.34-35, (Özet Bildiri)
2017
201747. Effect of verylow doses of cehmotherapeutic drugs on proangiogenic factors in tumor cells
Öçal M., Sonugür F. G., Babahan C., Abdi Abgarmi S., İÇLİ F., AKBULUT H.
ASCO 2017, 2 - 06 Haziran 2017, (Özet Bildiri)
2017
201748. Asingle center analysis of evolving experience with ALPPS procedure: Towards better patient and graft selection
BALCI D., KIRIMKER E. O., ÖZÇELİK M., ÜSTÜNER E., KONCA C., UTKAN G., et al.
12th Biennial E-AHPBA Congress 2017, Mainz, Almanya, 23 - 26 Mayıs 2017, (Özet Bildiri)
2017
201749. Tumor associated macrophages to predict the efficacy of bevacizumab plus chemotherapy in patients with advanced colorectal cancer.
AKBULUT H., Gunay F. S. D., Kirmizi B. A., Koksoy E. B., ENSARİ A., Icli F.
53rd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 2 - 06 Haziran 2017, cilt.35, (Özet Bildiri)
2017
201750. Effect of very low doses of chemotherapeutic drugs on proangiogenic factors in tumor cells.
Ocal M., Sonugur F. G., BABAHAN C., Abgarmi S. A., Icli F., AKBULUT H.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 2 - 06 Haziran 2017, cilt.35, (Özet Bildiri)
2017
201751. The effects of very low doses of chemotherapeutic drugs on endothelial cells.
Sonugur F. G., Ocal M., BABAHAN C., Abgarmi S. A., Icli F., AKBULUT H.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 2 - 06 Haziran 2017, cilt.35, (Özet Bildiri)
2017
201752. Metronomik Kemoterapinin Tümör Hücrelerinde Anjiyogenik Faktör Sentezi Üzerindeki Etkileri
ÖÇAL DEMİRTAŞ M., SONUGÜR F. G., BABAHAN C., Abdi Abgarmi S., AKBULUT H.
22. Ulusal Kanser Kongresi, Antalya, Türkiye, 17 - 23 Nisan 2017, (Özet Bildiri)
2017
201753. Evre III Mide kanseri adjuvant tedavisinde dosetaksel- sisplatin- fluorourasil(DCF) rejiminin etkinliği
ALKAN A., Mızrak D., karcı E., YAŞAR H. A., KÖKSOY E. B., Ürün M., et al.
22. Ulusal Kanser Kongresi, Antalya, Türkiye, 19 - 23 Nisan 2017, ss.256-257, (Özet Bildiri)
2017
201754. Kalp ve Beyin Metastatik Yassı Hücreli Dil Karsinomu Olgusu
ÜRÜN M., ÖZYURT N., KÖKSOY E. B., YAŞAR H. A., KARCI E., UTKAN G., et al.
22. Ulusal Kanser Kongresi, Antalya, Türkiye, 19 - 23 Nisan 2017, ss.321, (Özet Bildiri)
2017
201755. Onkoloji pratiğinde aşılama ve etkileyen faktörler
ALKAN A., karcı E., YAŞAR H. A., Tuncay G., KÖKSOY E. B., Ürün M., et al.
22. Ulusal Kanser Kongresi, Türkiye, 19 - 23 Nisan 2017, (Özet Bildiri)
2017
201756. Metronomik Kemoterapinin Endotel Hücre Fonksiyonları Üzerindeki Etkisi
SONUGÜR F. G., BABAHAN C., Abdi Abgarmi S., AKBULUT H.
22. Ulusal Kanser Kongresi, Antalya, Türkiye, 19 - 23 Nisan 2017, (Tam Metin Bildiri)
2017
201757. Metastatik Olmayan Kolorektal Adenokanserlerde Lenf Nodu Metastazı İçin Prediktif Faktörlerin Değerlendirilmesi
KARCI E., KÖKSOY E. B., HOCAZADE C., BİLGİN B., ALKAN A., DEDE İ., et al.
22. ULUSAL KANSER KONGRESİ, Antalya, Türkiye, 19 Nisan 2017, ss.242-243, (Özet Bildiri)
2017
201758. Evre III Mide Kanseri Adjuvant Tedavisinde Dosetaksel-Sisplatin-Fluorourasil (DCF) Rejiminin Etkinliği
ALKAN A., MIZRAK KAYA D., Karci E., Yasar A., Koksoy E. B., Ürün M., et al.
22. Ulusal Kanser Kongresi, Türkiye, 19 - 23 Nisan 2017, (Özet Bildiri)
2016
201659. Prognostic importance of bone marrow uptake on baseline 18F-FDG positron emission tomograpy/computed tomography in diffuse large B-Cell lymphoma
SOYDAL Ç., KÖKSOY E. B., YAŞAR H. A., TURGAL E., DOĞANAY ERDOĞAN B., AKBULUT H., et al.
Annual Congress of the European Association of Nuclear Medicine, 15 - 19 Ekim 2016, cilt.43, ss.317, (Özet Bildiri)
2016
201660. The role of immune system on the efficacy of bevacizumab in patients with metastatic colorectalcancer mCRC
AKBULUT H., Öcal M., Sonugür G., AKAY B., Bahahan C., Abgarmi S. A., et al.
ESMO Congress, 7 - 11 Ekim 2016, (Özet Bildiri)
2016
201661. TRPredictive factors of lymph node metastasis in patients with non metastatic colorectal Adenocarcinoma
Karcı E., KÖKSOY E. B., ALKAN A., Dede İ., Tuncay G., UTKAN G., et al.
ESMO Congress, 7 - 11 Ekim 2016, (Özet Bildiri)
2016
201662. Medical oncologists attitudes towards vaccination in oncology practice
ALKAN A., Karcı E., YAŞAR H. A., Tuncay G., Ürün M., KÖKSOY E. B., et al.
ESMO Congress, 7 - 11 Ekim 2016, (Özet Bildiri)
2016
201663. Vaccination in oncology practice and predictors
ALKAN A., KARCI E., YAŞAR H. A., TUNCAY G., ÜRÜN M., KÖKSOY E. B., et al.
ESMO, 7 - 10 Ekim 2016
2016
201664. Medical oncologists attitudes towards vaccination inoncology practice
ALKAN A., karcı e., YAŞAR H. A., tuncay g., ürün m., KÖKSOY E. B., et al.
ESMO annual meeting, 7 - 11 Ekim 2016, (Özet Bildiri)
2016
201665. Adjuvant concurrent chemoradiotherapy(CRT) plus docetaxelcisplatin-fluorouracil (DCF) versus CRT plus fluorouracil folinic acid (FUFA) in gastric cancer
Alkan A., Mizrak D., Karci E., Yasar A., Koksoy E. B., Urun M., et al.
41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Copenhagen, Danimarka, 7 - 11 Ekim 2016, (Özet Bildiri)
2016
201666. Predictive factors of lymph node metastasis in patients with non-metastatic colorectal adenocarcinoma
Karci E., Koksoy E. B., Alkan A., Dede I., Tuncay G., Utkan G., et al.
41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Copenhagen, Danimarka, 7 - 11 Ekim 2016, cilt.27, (Özet Bildiri)
2016
201667. Severe Drug Interactions and Potentially Inappropriate Medication Usage in Elderly Cancer Patients
ALKAN A., YAŞAR H. A., KARCI E., KÖKSOY E. B., ÜRÜN M., ÇAY ŞENLER F., et al.
ASCO, 6 - 10 Haziran 2016
2016
201668. Persistent postmastectomy pain syndrome and posttraumatic stress disorder among breast cancer survivors ORTHUS study A study of the palliative care working committee of the Turkish Oncology Group TOG
ALKAN A., Güç Z. G., ÇAY ŞENLER F., YAVUZŞEN T., Onur H., Doğan M., et al.
Annual Meeting of ASCO, Amerika Birleşik Devletleri, 1 - 04 Haziran 2016, (Özet Bildiri)
2016
201669. Mesenchymal stem cell directed baculoviral gene therapy of colon cancer.
Akbulut H., Aktas S. H., Elçin A. E., Parmaksız M., Keskin A. A., Cihan A. C., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34, (Özet Bildiri)
2016
201670. Severe drug interactions and potentially inappropriate medication usage in elderly patients with cancer.
Alkan A., Yasar A., Karci E., Koksoy E. B., Urun M., Senler F. C., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34, (Özet Bildiri)
2016
201671. Persistent postmastectomy pain syndrome and posttraumatic stress disorder among breast cancer survivors (ORTHUS study): A study of the palliative care working committee of the Turkish Oncology Group (TOG).
Alkan A., Guc Z. G., Senler F. C., YAVUZŞEN T., Onur H., Dogan M., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34, (Özet Bildiri)
2016
201672. Nadir bir vaka: Akciğer ve kolonda senkron multiple primer tumor
YAŞAR H. A., budak B., ALKAN A., AKBULUT H.
6. Türk Tıbbi Onkoloji kongresi, Antalya, Türkiye, 23 - 27 Mart 2016, ss.454, (Özet Bildiri)
2016
201673. Tam Remisyondaki opere meme kanseri hastalarında postmastektomi ağrı sendromu ile post traumatic stress bozukluğu ilişkisi (ORTHUS Çalışması)- Tük Onkoloji Grubu Destek Tedaviler Grubu
ALKAN A., Güç Z. G., ÇAY ŞENLER F., YAVUZŞEN T., onur H., Doğan M., et al.
6.Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 23 - 27 Mart 2016, ss.142, (Özet Bildiri)
2016
201674. Geriatrik kanser hastalarında ciddi ilaç etkileşimi ve uygunsuz ilaç kullanımı
ALKAN A., YAŞAR H. A., KARCI E., KÖKSOY E. B., ürün m., ÇAY ŞENLER F., et al.
6.Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 23 - 27 Mart 2016, ss.167, (Özet Bildiri)
2015
201575. The Effect of Melatonin Curcumin and Salermide on Sirt2 expression Level of Hippocampus in Middle Aged Rats
AKBULUT K. G., KESKİN AKTAN A., Mutlu Ç., AKBULUT H.
41st National Physiology Congress, Türkiye, 12 - 14 Eylül 2015
2015
201576. Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study
ÜRÜN Y., Abali H., Turna H., Esin E., Sedef A. M., Alkan A., et al.
European Cancer Congress, Vienna, Avusturya, 01 Ocak 2015, cilt.51, (Özet Bildiri)
2015
201577. The significance of the serum leptin, ghrelin, tumor necrosis factor alpha and interleukine-1 levels in patients with non-small cell lung cancer
Karatas F., Yalcin B., AKBULUT H., Utkan G., Sahin S., DEMİRKAZIK A., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2015
201578. Sequential use of bevacizumab and cetuximab in patients with K-RAS wild type advanced colorectal cancer.
AKBULUT H., Gercik O., Icli F., Mizrak D., DEMİRKAZIK A., Onur H., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2015
201579. The survival rate at 5 years in Turkish metastatic melanoma patients treated with ipilimumab: Final analysis of MIPI-TURK
Sevinc A., TURNA Z. H., Ozdogan M., Buyukberber S., Mandel N. M., Demir G., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2015
201580. 4 1 7 Endüstri ve Teknoloji Kanser Araştırmaları ve tedavilerini ne kadar etkiliyor
AKBULUT H.
Ulusal Kanser kongresi, Türkiye, 25 - 27 Nisan 2015, (Tam Metin Bildiri)
2015
201581. Nutrition foods poultry meat and cancer
AKBULUT H.
Third international poultry meat congress, 22 - 26 Nisan 2015
2014
201482. Preoperative systemic therapy for locally advanced breast cancer single center experience
MIZRAK KAYA D., Kubilay P., Berna K., Onur H., AKBULUT H.
San Antonio Breast Cancer Conference, 9 - 13 Aralık 2014
2014
201483. Serum levels of CEA and CA 15 3 in different subtypes of recurrent breast cancer
MIZRAK KAYA D., Öztürk B., Kubilay P., AKBULUT H., Onur H.
San Antonio Breast Cancer Conference, 9 - 13 Aralık 2014
2014
201484. More prognostic factors in early stage breast cancer
MIZRAK KAYA D., Öztürk B., Kubilay P., AKBULUT H., Onur H.
san Antonio Breast Cancer Conference, 9 - 13 Aralık 2014
2014
201485. Effect of tumor hormonal and HER2 status on localization of metastases in recurrent breast cancer
MIZRAK KAYA D., Onur H., Öztürk B., Kubilay P., AKBULUT H.
San Antonio Breast Cancer Conference, 9 - 13 Aralık 2014
2014
201486. Effect of HER2 and hormonal status to FDG uptake on PET CT imaging in recurrent breast cancer
MIZRAK KAYA D., Onur h., öztürk b., pınar k., UTKAN G., AKBULUT H.
SanAntonio Breast Cancer Conference, 9 - 13 Aralık 2014
2014
201487. Blood group is it associated with tumor biology in breast cancer
MIZRAK KAYA D., Öztürk B., Kubilay P., AKBULUT H., Onur H.
San Antonio Breast Cancer Conference, 9 - 13 Aralık 2014
2014
201488. Correlation of tumor marker levels with intensity of FDG uptake on PET imaging in epithelial cancers.
Mizrak D., ARAZ M., AKBULUT H., KÜÇÜK N. Ö., Alkan A., Yalcin S., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2014
201489. Over kanserli hastalarda serum CA125 düzeyi ile 18F-FDG-PET/BT pozitifliği arasındaki ilişkinin saptanması
Mızrak D., ARAZ M., AKBULUT H., Kubilay P., ALKAN A., KÜÇÜK N. Ö., et al.
5.Türk Tıbbi Onkoloji Kongresi, Türkiye, 19 - 23 Mart 2014, (Özet Bildiri)
2014
201490. Metastatik kolorektal kanserli hastalarda serum CEA düzeyleri ile 18F- FDG-PET/BT pozitifliği ilişkisi
Mızrak D., ARAZ M., ALKAN A., AKBULUT H., KÜÇÜK N. Ö., İÇLİ F.
5.Türk Tıbbi Onkoloji Kongresi, Türkiye, 19 - 23 Mart 2014, (Özet Bildiri)
2014
201491. Meme kanserli hastalarda serum CEA ve CA 15-3 düzeyleri ile 18F-FDG PET/BT pozitifliği arasındaki ilişki
Mızrak D., ARAZ M., AKBULUT H., ÖZTÜRK B., ALKAN A., KÜÇÜK N. Ö., et al.
5.Türk Tıbbi Onkoloji Kongresi, Türkiye, 19 - 23 Mart 2014, (Özet Bildiri)
2013
201392. Is anemia due to chronic disease the main cause of anemia in cancer patients?
Utkan G., Kenar G., AKBULUT H., DEMİRKAZIK A., Onur H., Icli F.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2013
201393. The vascular endothelial growth factor as a predictive and prognostic factor in patients with advanced gastric cancer treated with docetaxel, cisplatin, and 5-florouracil (DCF) regimen.
Aktas S. H., AKBULUT H., Yazici O., Zengin N., Akgun N., Ustuner Z., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2013
201394. Serum CEA and CA 15-3 levels according to breast cancer subtypes
Dede I., Utkan G., AKBULUT H., ÜRÜN Y., Mizrak D., Icli F.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2013
201395. Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK at 30 months of follow-up.
Sevinc A., TURNA Z. H., Ozdogan M., Buyukberber S., Demir G., Gokmen E., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2013
201396. Wnt1 gene expression alters heterogeneous population of prostate cancer cells; decreased expression pattern observed in CD133(+)/CD44(+)prostate cancer stem cells
Goksei G., Bilir A., Uslu R., AKBULUT H., Guven U., ÖKTEM G.
104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington, Kiribati, 6 - 10 Nisan 2013, cilt.73, (Özet Bildiri)
2012
201297. FIGHTING AGAINST CIGARETTE SMOKING AMONG MEDICAL STUDENTS-A SUCCESS STORY
Icli F., ODABAŞ D., Gonullu İ., AKBULUT H., Ozkan A., Olmez S., et al.
37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Avusturya, 28 Eylül - 02 Ekim 2012, ss.469, (Özet Bildiri)
2012
201298. Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK.
Sevinc A., TURNA Z. H., Ozdogan M., Buyukberber S., Demir G., Gokmen E., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri)
2012
201299. ABO blood group and the risk of breast cancer: Multicenter, case-control, observational study.
ÜRÜN Y., Koru-Sengul T., Altundag K., Utkan G., Onur H., AKBULUT H., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri)
2012
2012100. Smoking habits of relatives of patients (pts) with cancer.
Hayran M., Kilickap S., ELKIRAN E. T., AKBULUT H., Abali H., Yuce D., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri)
2011
2011101. The Significance of the Serum Leptin Ghreline Tumor Necrosis Factor Alpha and Interleukine 1 Levels in Patient With Non Small Cell Lung Cancer
ÜRÜN Y., YALÇIN B., KARATAŞ F., UTKAN G., YÜKSEL C., CANGIR A., et al.
The 2011 European Multidisiplinary Cancer Congress. Stockholm, Sweden, Stockholm, İsveç, 24 - 27 Eylül 2011, ss.612
2011
2011102. The Significance of the Serum Leptin, Ghreline, Tumour Necrosis Factor Alpha and Interleukine-1 Levels in Patients With Non-Small Cell Lung Cancer
ÜRÜN Y., Yalcin B., Karatas F., Utkan G., YÜKSEL C., Cangir A., et al.
European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, İsveç, 23 - 27 Eylül 2011, cilt.47, (Özet Bildiri)
2011
2011103. Status of Granulocyte Colony-Stimulating Factor Receptor in Tumour Tissue of Patients With Breast Cancer
Yalcin B., Gunaydin Y., Percinel S., Dogan M., ÜRÜN Y., Ozal F. G., et al.
European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, İsveç, 23 - 27 Eylül 2011, cilt.47, (Özet Bildiri)
2011
2011104. Relationship Between ABO and RH Blood Groups and K-Ras Phenotype in Patients With Colorectal Adenocarcinoma
ÜRÜN Y., Utkan G., Arslan O., AKBULUT H., Savas B., Senler F. C., et al.
European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, İsveç, 23 - 27 Eylül 2011, cilt.47, (Özet Bildiri)
2011
2011105. The role of serum osteopontin (OPN) as a prognostic and predictive marker in patients with advanced gastric cancer.
YAZICI O., AKBULUT H., Akgün N., UTKAN G., YALÇIN B., İÇLİ F.
ASCO 2011, 2 - 06 Haziran 2011, (Özet Bildiri)
2010
2010106. The Chemotherapeutic DRUGS at the Metronomic Doses Decrease Vascular ENDOTHELIAL GROWTH FACTOR (VEGF) Secretion of SOLID TUMORS
Aktas H. E., AKBULUT H., Akgun N.
9th International Meeting of the International-Society-for-the-Study-of-Xenobiotics(ISSX), İstanbul, Türkiye, 4 - 08 Eylül 2010, cilt.42, ss.162-163, (Özet Bildiri)
2010
2010107. Melatonin Decreases DNA Fragmantation and Oxidative STRESS PARAMETERS of Gastrointestinal Mucosa
AKBULUT K. G., AKBULUT H., Akgun N.
9th International Meeting of the International-Society-for-the-Study-of-Xenobiotics(ISSX), İstanbul, Türkiye, 4 - 08 Eylül 2010, cilt.42, ss.99-100, (Özet Bildiri)
2010
2010108. The role of Phe329 in the inhibition of human butyrylcholinesterase by malachite green and methyl green
Biberoglu K., Tacal O., AKBULUT H.
35th Congress of the Federation-of-European-Biochemical-Societies, Gothenburg, İsveç, 26 Haziran - 01 Temmuz 2010, cilt.277, ss.81, (Özet Bildiri)
2009
2009109. Inhibition of A277V mutant of human butyrylcholinesterase by malachite green
Biberoglu K., Tacal O., AKBULUT H.
34th Congress of the Federation-of-European-Biochemical-Societies, Prague, Çek Cumhuriyeti, 4 - 09 Temmuz 2009, cilt.276, ss.130, (Özet Bildiri)
2009
2009110. GM CSF augments tumor specific immune response and anti tumoral efficacy when combined with suicide gene therapy
AKBULUT H., ÇÖLERİ CİHAN A., AÇIKGÖZ N., ŞAHİN G., BAYDIN P., TANG Y., et al.
45th ASCO Annual Meeting, Orlando, 29 Mayıs - 02 Haziran 2009, cilt.27
2009
2009111. Effect of GM-CSF on tumor-specific immune response and antitumoral efficacy when combined with suicide gene therapy
AKBULUT H., Coleri A., Acikgoz N., Sahin G., Ozkal P., Tang Y., et al.
45th Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2009, cilt.27, (Özet Bildiri)
2008
2008112. Kronik Viral Hepatitlerde Lenfoproliferatif Hastalıklar
BOZKUŞ Y., İDİLMAN R., MIZRAK KAYA D., CENGİZ SEVAL G., Saykı M., Üstün Y., et al.
25. Ulusal Gastroenteroloji Haftası, Türkiye, 12 - 16 Kasım 2008, (Tam Metin Bildiri)
2008
2008113. Vector Prime-Protein Boost Vaccine induces 20 Fold Decrease in the Levels of CD44(+)CD24(-/Low) Cancer Stem Cells in Epithelial Neoplasms
Tang Y., AKBULUT H., Maynard J., Li P., Deisseroth A. B.
50th Annual Meeting of the American-Society-of-Hematology/ASH/ASCO Joint Symposium, San-Francisco, Kostarika, 6 - 09 Aralık 2008, cilt.112, ss.1000, (Özet Bildiri)
2008
2008114. TAA/ecdCD40L VPP Vaccination Induces Robust Adaptive Immune Response Even in Individuals with Post Transplantation Lymphopenia
Tang Y., Park Y. H., Maynard J., Li P., AKBULUT H., Petersen L., et al.
50th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2008, cilt.112, ss.141-142, (Özet Bildiri)
2006
2006115. Vaccine for prevention of breast cancer.
Deisseroth A., Tang Y., Maynard J., AKBULUT H.
42nd Annual Meeting of the American-Society-of-Clinical-Oncology, Georgia, Amerika Birleşik Devletleri, 2 - 06 Haziran 2006, cilt.24, (Özet Bildiri)
2006
2006116. Hepatitis B and C seroprevalance in cancer patients: A case control study
Utkan G., Azap A., Muallaoglu S., Tokluoglu S., Durnali A. G., Arslan U. Y., et al.
31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.297, (Özet Bildiri)
2006
2006117. Vector targeted chemotherapy plus vector vaccination can cure solid tumors
AKBULUT H., Tang Y., Akbulut G. K., Maynard J., Deisseroth A. B.
30th Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.143, (Özet Bildiri)
2005
2005118. Vector prime-protein boost vaccine induces immune response against "self-antigens" associated with epithelial neoplasms and tumor vascular endothelial cells.
Tang Y., Maynard J., AKBULUT H., Linton P., Deisseroth A.
47th Annual Meeting of the American-Society-of-Hematology, Georgia, Amerika Birleşik Devletleri, 10 - 13 Aralık 2005, cilt.106, (Özet Bildiri)
2005
2005119. The evaluation of the hydrotalcite effectiveness on prophylaxis and treatment of mucositis due to high dose methotrexate treatment in osteosarcoma patients: A prospective crossover trial.
Utkan G., Tek I., Doruk H., Yalcin B., Buyukcelik A., AKBULUT H., et al.
41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 13 - 17 Mayıs 2005, cilt.23, (Özet Bildiri)
2005
2005120. Irinotecan plus oral etoposide (IRET) combination is an highly active and promising treatment in heavily pre-treated small cell lung cancer patients.
AKBULUT H., Tek I., Demirkazik A., Icli F., Doruk H., Yalcin B., et al.
41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 13 - 17 Mayıs 2005, cilt.23, (Özet Bildiri)
2005
2005121. The relationship between serum cholesterol level and axillary lymph node statu in breast cancer patients
Utkan G., Onur H., Akbulut H., Yalcin B., Buyukcelik A., Tek I., et al.
28th Annual San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 8 - 11 Aralık 2005, cilt.94, (Özet Bildiri)
2004
2004122. Divided doses of cisplatin in combination with gemcitabine for patients with advanced non-small cell lung cancer (NSCLC).
Demirkazik A., Yalcin B., AKBULUT H., Buyukcelik A., Cay F., Utkan G., et al.
40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22, (Özet Bildiri)
2004
2004123. Addition of 2 cycles of EP (Etoposide plus Cisplatin) to the 4 cycles of adjuvant AC (doxorubicin plus cyclophosphamide) improves the survival in node positive patients with breast cancer after 10 years
Icli F., AKBULUT H., Dincol D., Onur H., Demirkazik A., Cam R., et al.
40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22, (Özet Bildiri)
2004
2004124. The prognostic role of serum telomerase activity in advanced breast cancer receiving anthracyclines.
AKBULUT H., Temizkan S., Arican A., Zengin N., Yalcin B., Icli F.
40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22, (Özet Bildiri)
2004
2004125. Vector vaccine overcomes anergy.
Deisseroth A., Tang Y., Zhang L., AKBULUT H., Linton P.
40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22, (Özet Bildiri)
2003
2003126. An adenoviral vector cancer vaccine that delivers a tumor-associated antigen/CD40-ligand fusion protein to dendritic cells
zhang l., Tang Y., AKBULUT H., Zelterman D., linton P., Deisseroth A.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, 6 - 08 Aralık 2003, (Özet Bildiri)
2003
2003127. An adenoviral vector cancer vaccine that delivers a tumor associated antigen/CD40-ligand fusion protein to dendritic cells in vivo and thereby breaks tolerance to tumor associated self antigens.
Tang Y., Zhang L., AKBULUT H., Litton P., Deisseroth A.
45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 Aralık 2003, cilt.102, (Özet Bildiri)
2003
2003128. Lamivudine prophylaxis for prevention of chemotherapy induced hepatitis B virus reactivation in hepatitis B virus carriers with hematological malignancies
Idilman R., Arat M., TÖRÜNER M., Soykan I., Karayalcin S., Soydan E., et al.
38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Türkiye, 29 Mart - 01 Nisan 2003, cilt.38, ss.146-147, (Özet Bildiri)
Kitaplar
2024
20241. Kanser Biyolojisi
Babahan C., Sonugür F. G., Akbulut H.
İç Hastalıkları, İliçin Gürler,Biberoğlu Kadir,Süleymanlar Gültekin,Ünal Serhat, Editör, Güneş Tıp Kitabevi, Ankara, ss.1659-1670, 2024
2023
20232. Viral Vektör Aşıları
Sonugür F. G., Babahan C., Akbulut H.
Aşı Çalışmaları ve Teknolojisi, Mert Döşkaya,Adnan Yüksel Gürüz,Ayşe Gülten Kantarcı,Cemal Ün, Editör, Nobel Tıp Kitabevi, Ankara, ss.355-382, 2023
2020
20203. Hedefe Yönelik Ajanlar ve COVID-19
Köksoy E. B., Akbulut H.
Kanser ve COVID-19 Pandemisi, Yalçın Ş,Özet A, Editör, Türkiye Klinikleri, Ankara, ss.95-100, 2020
2016
20164. Kanserde Gen Tedavisi
Aktaş S. H., Baydın P., Akbulut H.
Kanser, Prof. Dr. Mustafa Altınbaş, Editör, DNT Ortadoğu Yayıncılık, Ankara, ss.1372-1383, 2016
2002
20025. Prevention of Cervical Cancer: Chemoprevention
Akbulut H., Deisseroth A.
Progress in Oncology 2002, DeVita V,Hellman S,Rosenberg SA, Editör, Jones and Barlett Publishers , Massachusetts, ss.251-269, 2002
Desteklenen Projeler
2023 - 2025
2023 - 2025Instrument for Pre-Accession regulation (IPA II) Ankara Innovative Theranostics Development Center (AnkaTheraHub)
AB IPA Projesi
Akbulut H. (Yürütücü), Babahan C., Sonugür F. G.
2022 - 2023
2022 - 2023Replikasyon Defektif Adenovirüsün Apoptoz ve Otofaji Yolaklarının Tümör Hücre Hatları Üzerinde Etkileri
Yükseköğretim Kurumları Destekli Proje , BAP Y.Lisans
AKBULUT H. (Yürütücü), KORGAN E.
2022 - 2023
2022 - 2023Replikasyon Defektif Tip 5 Adenoviral Vektörlerin Tümör Hücrelerinde Sitokin Gen Ekspresyonuna Etkileri
Yükseköğretim Kurumları Destekli Proje , BAP Y.Lisans
AKBULUT H. (Yürütücü), ZENGİN İ.
2017 - 2020
2017 - 2020İmmün Denetim Noktalarını Hedefleyerek Tedavi Seçimini Belirleyen Radyofarmasötik Geliştirilmesi
TÜBİTAK Projesi , 1003 - Öncelikli Alanlar Ar-Ge Projeleri Destekleme Programı
Soydal Ç., Akbulut H., Küçük N. Ö. (Yürütücü)
2016 - 2017
2016 - 2017Kanser Hücrelerinde Anjiyogenik Faktörlerin Ekspresyonuna Kemoterapinin Etkilerinin İncelenmesi
Yükseköğretim Kurumları Destekli Proje , BAP Y.Lisans
AKBULUT H. (Yürütücü)
2016 - 2017
2016 - 2017Metronomik kemoterapinin endotel hücre fonksiyonları üzerindeki etkisi
Yükseköğretim Kurumları Destekli Proje , BAP Y.Lisans
AKBULUT H. (Yürütücü)
2013 - 2014
2013 - 2014Kolorektal Kanserli Hastalarda Kök Hücre Gen Ekspresyon Profili ve Prognostik Önemi
Yükseköğretim Kurumları Destekli Proje , BAP Y.Lisans
AKBULUT H. (Yürütücü)